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ABSTRACT

Nasir, Amjad, Ph.D., Purdue University, May 2015. Developmentally Regulated
SUMOylation in the ciliate Tetrahymena thermophila. Major Professor: James D.
Forney.

The Small Ubiquitin-like MOdifier (SUMO) protein regulates numerous nuclear
events such as transcription, mitosis and meiosis and DNA repair. These processes
are critical to the programmed nuclear events of conjugation in ciliates and provide
the potential to investigate developmentally regulated SUMOylation. We predicted a
developmental increase in SUMOylation during late conjugation based on the
extensive genome remodeling in the developing macronucleus (anlagen) of
Tetrahymena thermophila. Immunoblotting of cell lysates from vegetative and
mating cells using anti-SUMO antibodies revealed distinct developmental
differences and an increased signal correlated with formation of the anlagen.
Immunofluorescence of mating Tetrahymena cells with the same antibody revealed
an increase in staining of the parental macronucleus until the signal shifts to the
anlagen at 7 hours post-mixing. This along with the finding that GFP-Uba2 fusion
proteins localize to the anlagen is consistent with a major nuclear role for
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SUMOylation during conjugation. Germ-line knockout mutants of SUMO (SMT3) and
UBA2 are vegetative lethal and conditional mutants dependent on a cadmiuminducible metallothionein promoter exhibit reduced cell growth and increased
sensitivity to DNA damaging agents upon cadmium withdrawal. Interestingly,
mating of Uba2p conditional lines leads to a cadmium-dependent delay after meiosis
but prior to macronuclear development predicting a SUMOylation-dependent event.
Additionally, in an effort to provide further insight into the various processes
affected by SUMO modification, we utilized a proteomics-based approach to
generate an unbiased spectrum of SUMO protein substrates from vegetative
Tetrahymena. We used a two-step affinity purification scheme to isolate SUMO
substrates from a tagged Tetrahymena strain. Proteins from the purification were
then identified by subsequent LC-MS.MS analysis using a QuadTOF mass
spectrometer. We identified 110 candidate proteins that were identified by 2 or
more peptides. The nature of the protein substrates that were identified is
consistent with roles of SUMOylation in modulating diverse cellular processes
including transcriptional regulation, protein folding and translation, metabolism
and crosstalk with other post-translational modifications. These results support
multiple roles of SUMOylation in regulating various cellular processes in eukaryotic
cells. Taken together, our findings provide the foundation for additional studies of
SUMOylation during conjugation in Tetrahymena.
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CHAPTER 1 – INTRODUCTION
SUMO is a Member of the Ubiquitin-like Protein Family
Protein function is often regulated though additional or removal of molecular
adducts collectively termed post-translational modification (PTM). Because of the
dynamic nature of such modifications, PTMs are capable of rapid modulating
protein function by affecting stability, localization as well as interaction with other
proteins thereby altering the cellular proteome. Ubiquitin-like (UBL) or ubiquitinrelated modifiers are post-translationally attached to substrate proteins via an
enzymatic pathway reminiscent to that used in ubiquitin (Ub). SUMOylation is one
such UBL modification which involves the reversible and covalent conjugation of
members of the SUMO (Small Ubiquitin-like MOdifier) family of proteins to various
target proteins. Even though SUMO belongs to the Ub-like family of modifiers, its
functions are very diverse and different from Ub itself.

SUMO Isoforms and Structure
SUMOylation affects several critical processes in eukaryotic cells and is
required for cell viability in most eukaryotic systems (reviewed in (1)). Simple
eukaryotes such as yeast, fruit fly and nematodes express a single SUMO gene.
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In yeast, the SUMO homolog is named Smt3 (Suppressor of Mif Two 3) and
the same nomenclature will be used throughout this thesis when referring to the
gene (SMT3) or its product (Smt3p) in Tetrahymena (Table 1). There are four
isoforms of the SUMO protein in mammalian cells, with SUMO-2 and SUMO-3 (also
abbreviated as SUMO-2/3) sharing 97% sequence identity with one another and
only ~50% identity with SUMO-1 (reviewed in (2)). A fourth SUMO protein (SUMO4) has been described in humans, and is expressed primarily in kidney cells (3).
SUMO-1 shares the highest sequence similarity with SUMO in yeast and most lower
eukaryotes and is the primary isoform that is conjugated on to protein substrates
under normal conditions. SUMO2/3-adducts appear when cells undergo
physiological stress although there are examples of proteins such as topoisomerase
II, which disentangles DNA strands during replication, and CENP-E, which is a
component of centromeres in mammals, that are modified by SUMO-2/3 under
normal conditions too (4, 5). While there have been reports on paralog-specific
functions of SUMO-2/3, these proteins display functional redundancy and have
considerable overlap in substrate specificities with SUMO-1 (6, 7).
The structures of human (8) and yeast (9) SUMO variants have been resolved
recently and tertiary structures of both Ub and SUMO are very similar and nearly
superimposable even though SUMO proteins share very little (~18%) sequence
similarity with Ub (Figure 1) (10). A distinguishing characteristic of SUMO is that it
contains an elongated and flexible N-terminal neck region that has been linked to
polySUMO chain formation (11, 12). Remarkably, yeast mutants that lack the
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extended neck region including the lysine residues required for auto-SUMOylation
are viable without deleterious phenotypes which would suggest that, unlike Ub, the
formation of polymeric SUMO chains is not essential in S. cerevisiae (13). Another
similarity between SUMO and Ub is that the mature forms of both proteins end with
two glycine residues (diglycine motif) necessary for conjugation of these proteins to
lysine residues on target proteins (reviewed in (14, 15)).

Table 1. Nomenclature of SUMO Pathway Enzymes in Model Systems.
Enzyme
SUMO paralogs

E1 Activating
Enzyme
E2 Conjugating
Enzyme
E3 Ligases

SUMO Proteases

Humans/Mammals S. cerevisiae
SUMO-1
Smt3p
SUMO-2
SUMO-3
SUMO-4
SAE1/SAE2
Aos1p/Uba2p

T. thermophila
Smt3p

UBC9

Ubc9p

Ubc9p

PIAS1
PIAS3
PIASx
PIASy
Mms21

Siz1p
Siz2p or Nfi1p

Unidentified
Unidentified

Mms2p or
Zip3p
Unidentified
Unidentified
Ulp1p

Unidentified

Pc2
RanBAP
SENP1
SENP2
SENP3
SENP5
SENP6
SENP7

Ulp2p or
Smt4p

Aos1p/Uba2p

Unidentified
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SUMOylation in Human Disease
In the past few years, there have been increasing reports linking
SUMOylation to human disease pathogenesis. Most notably, dysregulation of the
SUMO pathway has been implicated in tumorigenesis and cancer onset (reviewed in
(16, 17)). This is not surprising as SUMOylation regulates important tumor
suppressor proteins such as p53, MDM2 and pRB (16). The link between
SUMOylation and cancer is further solidified by several studies where increased
levels of SUMO E1 Activating enzyme (18, 19), E2 Conjugating enzyme (20), SUMO
E3 ligases (21) and SUMO proteases (22, 23) have been shown to contribute to
human cancers. Myc is an oncogenic transcription factor frequently dysregulated in
human cancer. In human breast cancer, SAE2 (Uba2p in S. cerevisiae and T.
thermophila) is required for Myc-dependent tumorigenesis and patients with high
levels of SAE2 suffer from increased metastasis (19). Inhibition of SUMOylation in
this case may provide therapeutic benefits for patients with Myc-driven cancers.
Many proteins that play critical roles in neurodegenerative diseases have
also been identified as targets of SUMO. This list includes, but is not limited to,
huntingin (Huntington’s disease), ataxin-1 (spinocerebellar ataxia type 1), tau
protein (Parkinson’s and Alzheimer’s disease) and SOD1 (amyotrophic lateral
sclerosis) (reviewed in (24)). Diabetes, which is a very common human disease, has
also been linked to SUMOylation (25, 26). In mouse, the transcription factor c-Maf is
a target of SUMO. SUMOylation of c-Maf reduces its transactivational capacity by
sequestering it in promyelocytic leukemia nuclear bodies (PML-NBs). This prevents
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c-Maf from binding to interleukin IL-4 which otherwise confers resistance to
diabetic state (26). A similar study in mouse showed that overexpression of SUMO-2
negatively regulates the transcriptional factor NF-κB. The reduced activity of NF-κB
confers protection against diabetes in transgenic mice overexpressing SUMO-2 as
NF-κB is unable to activate genes involved in the development of Type-1 diabetes
(reviewed in (27)). Another major human disease linked to SUMOylation is
cardiomyopathy which most commonly causes heart failure. Overexpression of the
SUMO protease, SENP5 has been shown to result in elevated apoptosis leading to
cardiac dysfunction (28). The increase in cell apoptosis is also seen with
overexpression of the SUMO conjugating enzyme, Ubc9p where such apoptotic
events precede other detectable pathological changes suggesting its underlying role
in cardiomyopathy (29). Understanding the role of SUMOylation in human disease
is, therefore, of tremendous utility as it provides insights into functions of protein
substrates and mechanistic pathways that, when perturbed, cause diseased states.

The SUMO Conjugation Pathway Involves 3 Enzymes
SUMO-Activating Enzyme
Modification of proteins by SUMO occurs through a biochemical pathway that
is similar to attachment of Ub to target proteins (30). The first step in the pathway
utilizes an E1-activating enzyme which is a heterodimer comprised of two subunits
– SAE1 and SAE2 known as Aos1 and Uba2 in yeast respectively (31, 32) (Table 1
and Figure 1). It is interesting to note that Aos1 and Uba2 resemble the amino- and
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carboxyl-termini of Ub E1 enzymes (6, 32–34). Activation of SUMO occurs through
an ATP-dependent step in which the carboxyl group of the C-terminal glycine of
SUMO forms a thioester bond with a cysteine residue in the active site of the Uba2
component of the E1 enzyme. In most eukaryotic organisms, there is a single E1
enzyme required for the activation of SUMO proteins (6). This is in stark contrast to
the Ub system, where several E1 enzymes (8 in humans for example) are known to
initiate Ub activation (35, 36). There is no overlap of function between SUMO E1
enzymes (as well as E2 and E3 enzymes) with the Ub system and vice-versa. In
mammals and vertebrates, the single SUMO E1 enzyme will activate all isozymes of
SUMO (34, 37). Budding yeast strains that lack Aos1 or Uba2 exhibit a lethal
phenotype which indicates that the SUMO E1 is an essential enzyme in this
organism (32, 33). In fission yeast, S. pombe, Aos1 deletion mutants are able to
conjugate SUMO on to protein substrates at very low levels (38). This would suggest
that Uba2 is the essential component of the E1 enzyme as it contains the catalytic
active site. A less likely explanation would be that Aos1 paralogs from other UBL
modifications may substitute for Aos1.
Uba2 is expressed in all stages of Drosophila life cycle with an increase during
embryogenesis that would indicate a requirement for SUMOylation during this stage
of the life cycle (39). In the ciliate Tetrahymena thermophila, UBA2 transcripts are
expressed throughout the vegetative life cycle but are most abundant during the
sexual life cycle with a peak during the later stages corresponding to the generation,
development and maturation of new somatic nuclei (40). This expression pattern is
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consistent with the observation that E1 enzymes are found predominantly in the
cell nuclei of other eukaryotic model systems (6, 33, 39).

SUMO-Conjugating Enzyme
In the second step of the SUMO conjugation pathway, activated Smt3p is
transferred from the E1-activating enzyme to a cysteine residue in the active site of
the E2-conjugating enzyme. Unlike the Ub system which displays a greater diversity
of E2 enzymes, only a single E2 SUMO-conjugating enzyme, known as Ubc9, has
been identified as of yet (7) (Table 1 and Figure 1). A second distinguishing feature
of Ubc9 from other Ub E2 enzymes is that it is able to directly recognize substrate
proteins and catalyze the formation of isopeptide bond between SUMO and
substrate proteins in the absence of E3 ligases (reviewed in (2)).
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Figure 1. SUMOylation occurs through a 3-step enzymatic pathway. Conjugation of
Smt3p to substrate proteins occurs through a 3-step cascade that shares numerous
similarities to the ubiquitin pathway. Precursor Smt3p undergoes cleavage by SUMO
proteases to produce mature Smt3p revealing a C-terminal diglycine motif. Mature
Smt3p is then activated by the E1 Activating enzyme, which is a heterodimer of
Uba2p and Aos1p, in an ATP-dependent manner (only Uba2p is shown here). The E2
conjugating enzyme, Ubc9p, assisted by several adapter proteins known as SUMO E3
ligases, will then conjugate Smt3p onto a Lys residue of the substrate protein. SUMO
proteases are also responsible for removing Smt3p moiety from substrates
generating free Smt3p in the process.

SUMO-Ligating Enzymes
In the final step of the SUMO pathway, the SUMO-E2 thioester intermediate
serves as a donor in the conjugation of SUMO moiety onto a substrate protein. The
terminal glycine in SUMO forms an isopeptide bond with the ϵ amino group of a
lysine residue in the target protein. Three groups of proteins have been identified in
recent years that accelerate the conjugation of SUMO onto substrate proteins. These
proteins share very few recognizable features and are collectively known as SUMO
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E3 ligases. Surprisingly, these SUMO E3 ligases bear no semblance to typical Ub E3
ligases. The most famous SUMO E3 enzymes are the Siz/PIAS family of proteins that
contain the SP-RING that is analogous to RING domains of Ub E3 ligases. Siz/PIAS
proteins bind to the E2-SUMO thioester intermediate and protein substrates which
brings them in close proximity and promotes Smt3p transfer (reviewed in (2, 41)).
A second and distinct class of E3 enzymes is represented by RanBP2 that sits
at the nuclear pore complex and aids in the SUMO-modification of its target
RanGAP1. RanBP2 does not contain either RING or HECT domains that are found in
Ub E3 ligases and its E3 ligase domain favors preferential modification of RanGAP
with SUMO-1 over modification by SUMO-2 in mammalian systems (41). RanBP2
does not recruit RanGAP1 to Ubc9 but rather alters the structure of the SUMO-1Ubc9 thioester intermediate such that it has increased capacity to transfer SUMO to
its RanGAP1 substrate.
The last group of SUMO ligases comprise the human polycomb group protein
2 (Pc2) which is a member of a large multi-protein complex that regulates
transcriptional repression by altering chromatin structure. The effect of Pc2 in the
increased SUMOylation of its substrate CtBP2 is modest and direct interactions
between Pc2 and the SUMO-Ubc9 thioester intermediate have not been noted
(reviewed in (41)).
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Substrate Selection for SUMOylation
Attachment of SUMO to target proteins occurs on lysine residues that are
typically part of the SUMO-modification consensus motif, ψKXE (where ψ
represents aliphatic amino acids such as leucine, isoleucine and valine, and X is any
amino acid) (reviewed in (42)). There are a few examples where glutamate, E in the
SUMO tetrapeptide motif can be substituted with an aspartate, D (reviewed in (2,
43)). It is to be noted that SUMOylation does not always occur within this motif and
many lysines on substrate proteins that do not conform to the consensus motif are
SUMOylated. An example of this is PCNA which is SUMOylated on two lysine
residues: one of which resides in the consensus SUMO tetrapeptide motif while the
other lysine residue does not and is present in a different location.
At the same time, presence of the SUMO consensus tetrapeptide does not
guarantee attachment of Smt3p which would suggest that other factors such as
subcellular localization and availability of target lysines may also contribute to
modification by SUMO (42). Whilst the requirements for SUMOylation are quite
simple, identification of proteins as SUMO substrates based on the presence of the
ψKXE sequence is not sufficient. As a result, methods that evaluate SUMOylation of
the global proteome are increasingly gaining favor (44–48).

SUMO Processing and DeSUMOylation by SUMO Proteases
SUMO proteins are synthesized in the cell as precursor proteins that need to
be proteolytically cleaved to generate the mature C-terminus. SUMO proteases,
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designated Sentrin/SUMO-specific proteases (SENPs) expose the terminal glycine
residue that is linked to the target lysine on substrate proteins. The terminal glycine
forms part of the diglycine motif – two glycine residues in tandem that are highly
conserved in Ub and UBL family of proteins (15, 49, 50). The removal of conjugated
SUMO from substrates is also catalyzed by the action of SUMO proteases making
SUMOylation a cyclical and reversible process (reviewed in (14)). SUMO proteases
remove SUMO from substrates in response to stimuli and in doing so generate a free
pool of SUMO protein that can be conjugated to substrate proteins as needed. Two
SUMO proteases have been described in yeast, Ulp1 and Ulp2 with the former
essential for viability (reviewed in (14)). Deletions in Ulp2 in yeast result in cells
that viable but grow abnormally and are hypersensitive to DNA-damaging drugs
(51, 52).
It is of interest to study the mechanisms by which Ulp1 or SENPs proteases
deSUMOylate proteins that are SUMO-modified because of their function in quick
termination of SUMO-modification in response to various stimuli. The fewer number
of proteases identified in the SUMO system (as compared to the much more complex
Ub system) would suggest that these few proteases are highly active enzymes
and/or there are SUMO proteases that may be identified in future studies.
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Regulation of SUMOylation as a PTM
Control of Global SUMOylation
The primary method of regulating global SUMOylation in the cell is by
regulating the expression or activity of the enzymes of the SUMOylation pathway.
An overall increase in SUMOylation levels has been observed in response to ethanol
stress, hydrogen peroxide and heat shock (47, 53). On the other hand,
downregulation of the total SUMOylation is observed when the amount of reactive
oxygen species is decreased (54). This type of control is exercised by formation of a
disulfide bond between the active site cysteine residues of E1 and E2 enzymes
rendering them defunct to participate in SUMOylation. In the Ub system, E1
enzymes, in addition to their primary role in activating Ub, can also establish
substrate specificity by matching up with cognate E2s. The E2 enzyme Ubc9 itself
possesses not only the capacity to catalyze SUMO transfer to the substrate, but also
the capacity to select the lysine residue for modification. Because the SUMOylation
pathway relies on a single E1 and E2, the regulation of these enzymes allows the cell
to regulate the entire SUMO proteome at any given time. Stability of the E1 and E2
enzymes is another mechanism by which the cell can modulate the activities
associated with the SUMO pathway. For example, chicken adenovirus GAM1 controls
E1 turnover by binding to the SAE1 (Aos1p) component and recruiting Cullin-RING
Ub ligases that target it for degradation by the proteasome (55, 56). Decrease in
SAE1 levels causes a drop in SAE2 (Uba2p) levels concomitantly (56). GAM1 also
reduces E2 enzyme Ubc9p levels to lower overall SUMOylation although the
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mechanism of this inhibition is not fully understood (55). Pathogens like the
bacterium Listeria monocytogenes infiltrate host defenses by impairing global
SUMOylation by targeting Ubc9 as well as other SUMOylated proteins for
proteasomal-mediated degradation (57).
Other methods to regulate SUMO pathway enzymes include sequestering of
SUMOylation enzymes in different locations inside the cell. In budding yeast, the
SUMO E3 ligase Siz1 is responsible for SUMOylation of septins. Siz1 is contained in
the nucleus during interphase and at the onset of mitosis, it is release to the
cytoplasm where it accumulates at septin rings and participates in their
SUMOylation (58). Alcohol-induced stress in the same organism results in a rapid
accumulation of the Smt3p protease Ulp1 in the nucleolus which consequently
results in a dramatic increase in the levels and SUMOylation state of protein
substrates (59). It is generally thought that SUMO E3 ligases (in addition to the
identification of substrates by Ubc9) regulate SUMOylation as a PTM by displaying
substrate preferences and in some cases, SUMO isoform-specific conjugation of
particular targets (60).

Crosstalk with other PTMs
PTM modification by SUMO, Ub, and acetyl groups use lysine residues for
attachment and it has become apparent over the course of several years that these
PTMs can form a combinatory molecular switch to synergize or antagonize with
each other adding yet another layer to protein regulation (reviewed in (61, 62)). As
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these PTMs utilize lysines for covalent attachment, it is plausible that they compete
with each other to bring about a more complex mechanism of protein regulation. A
distinct function of Smt3p is to protect target proteins from Ub-mediated
degradation. This is best exemplified in IκBα, an inhibitor of NF-κB transcription
factor, which is degraded by Ub marking in cells responding to inflammation. In
unstimulated cells, IκBα is protected from Ub-mediated degradation through
SUMOylation which uses up the lysines otherwise targeted by Ub (63). Another
example is cAMP response element binding protein (CREB) that is degraded in
mammalian cells suffering from hypoxic stress. Overexpression of SUMO-1 stabilizes
CREB in hypoxia which suggests a similar mechanism of protection offered by
SUMOylation against ubiquitylation (reviewed in (64)).
There are cases, however, when Ub and SUMO act less antagonistically
providing evidence for crosstalk between the two PTMs. Many substrates of SUMO
contain a specific protein motif, denoted SUMO Interacting Motif (SIM) that is
characterized by a sequence motif of hydrophobic amino acids V/I-X-V/I-V/I. These
hydrophobic residues of the SIM domain contact a hydrophobic patch within SUMO
(reviewed in (2)). RNF4, which belongs to a class of proteins referred as SUMOtargeted Ub ligase (STUBl), houses four SIMs which recognize SUMO moieties on
target proteins. Upon recognition of polySUMO chains on proteins, RNF4 will start
ligating Ub on the SUMO-modified protein thereby marking the protein for
degradation by the proteasome (65).
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In addition to the SUMO consensus tetrapeptide motif, the highly conserved
phosphorylation-dependent SUMOylation motif (PDSM), that comprises the SUMO
consensus motif and an adjacent proline-directed phosphorylation site (ψKXEXXSp;
where serine is phosphorylated), has been described (reviewed in (42)). Some
examples of proteins that are regulated both by SUMOylation and phosphorylation
(referred as phospho-SUMOyl switch) are heat-shock factors (HSF), and peroxisome
proliferator-activated receptor γ (PPARγ) and myocyte enhancer factor 2 (MEF2)
(reviewed in (66)). In these cases, phosphorylation of the serine residue of the
PDSM enhances SUMOylation as the negative phosphate group interacts with a basic
path on the E2 Ubc9 enzyme (reviewed in (2)). Apart from such a phospho-SUMOyl
switch, phosphorylation of SUMO substrates is also shown to regulate the
SUMOylation state of the proteins. In some cases, dephosphorylation event at a
PDSM causes a loss of the SUMO from the same PDSM motif. This decreased
SUMOylation is coupled with increased acetylation indicating yet another variant of
the SUMO consensus tetrapeptide – an acetyl-SUMOyl switch based on
communication between SUMOylation and acetylation (67, 68). Acetylation of the
target lysine within the PDSM blocks SUMOylation, leading to transcriptional
activation through inhibition from SUMO-mediated repression (reviewed in (42)).
SUMO proteins can be modified by acetyl groups further contributing to the
regulation of SUMOylation. In mammals, SUMO-1 is targeted for acetylation which
results in neutralizing of basic charges in its SIM docking sites and consequently
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lowers its binding affinity to SIM domains in substrates such as PML, Daxx and PIAS
proteins (67).

Biological Functions of SUMOylation
SUMOylation and Inhibition of Gene Transcription
Many SUMO-modified proteins reside in the nucleus but cytosolic targets
have also been identified. The most prominent group of proteins that have been
identified as SUMO substrates are transcription factors. These proteins are active in
the nucleus where they regulate gene expression by modulating transcription.
Mutations that prevent modification by SUMO in the transcription factors Elk-1 and
Sp-3 result in an increase in transcription from respective promoters linking SUMO
to repression of gene expression (69, 70). The role of SUMOylation in
downregulating transcription is further reinforced by the observation that simply
targeting SUMO or Ubc9 to promoters has been shown to reduce promoter activity
(71). While not much is known about the general mechanism by which SUMOylation
regulates transcription, it is becoming increasingly apparent that SUMOmodification results in interactions between transcriptional factors and
transcriptional co-repressors such as chromatin modifying proteins that induce a
more heterochromatic state (reviewed in (42)). For example, the histone
deacetylase HDAC6 is able to bind to its co-repressor p300 only when it is
SUMOylated ((1)). Another such interaction is seen in the case of PIAS proteins
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(SUMO ligases) and Sp3 where PIAS binds strongly to SUMO-modified Sp3 than
unmodified Sp3 (reviewed in (1)).

SUMOylation is Required for Maintenance of Genome Integrity
SUMOylation was first linked to DNA repair with the finding that thymine
DNA glycosylase (TDG), a base excision repair enzyme that removes thymine or
uracil from T-G or U-G mismatched base pairs, is a substrate of SUMO. TDG removes
harmful DNA lesions leaving an abasic site to which it binds tightly. TDG has to be
SUMOylated for it to relax its hold on the DNA helix which allows repair to occur
quickly by downstream enzymes and frees up the TDG to seek other base lesions
(72–74).
SUMO E3 ligases such as the PIAS proteins in mammals have been implicated
in genome stability (75, 76). PIAS proteins are components of the DNA damage
repair pathways and aid in the SUMOylation and subsequent recruitment of repair
proteins to sites of double strand breaks (DSBs) (75). Although SUMOylation is
important for response to DNA damage, it has also been demonstrated that
deSUMOylation via the action of SUMO proteases also plays a role in genomic
maintenance. The SUMO protease Ulp1 in yeast is an essential gene required for cell
viability and Ulp2 mutant cells are viable but suffer from hypersensitivity to DNA
damaging agents (51, 52). Taken together, these observations would suggest that
SUMOylation and deSUMOylation may be coupled together in response to genotoxic
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stress to regulate the assembly and disassembly of protein factors involved in the
repair response.

SUMOylation in Chromosome and Sub-nuclear Structure
It is not surprising that a growing body of work links SUMOylation to the
control of chromosome dynamics. In fact, all SUMO-pathway components (E1, E2, E3
and SUMO proteases) have shown genetic associations with maintenance of
chromosome structure and segregation events. In S. pombe, complete disruption of
the Smt3p homolog, Pmt3, results in cells that are barely viable and suffer from
defects in mitosis and chromosome segregation (77). In the budding yeast S.
cerevisiae, mutants of the E1-activating enzyme Uba2 display hypersensitivity to
microtubule destabilizing drugs and arrest early in mitosis with short and
frequently misaligned spindles (78). Yeast Ubc9 mutants are unable to
appropriately activate the anaphase promoting complex (APC) that helps in the
progression through mitosis (79).
SUMOylation has a well-defined role in dictating sub-nuclear architecture.
This is best exemplified in the case of promyelocytic leukemia (PML) nuclear-bodies
(PML NBs), where SUMOylation is necessary for maturation of the tumor
suppressor protein PML which is the primary component of PML NBs (80, 81). PML
NBs exemplify the function of the SUMO Interacting Motif (SIM) that are
characterized by a tetrapeptide sequence motif of hydrophobic amino acids that
make contact with a hydrophobic patch within the SUMO protein (reviewed in (2)).
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SUMOylation of PML plays a critical role in its activity of recruiting partners, many
of which are SUMOylated themselves. The ever increasing list of proteins of the PML
complex also includes proteins that specifically recognize SUMOylated partners via
their SIM domains. A combination of SUMO conjugation on target proteins and SIM
domains on interacting partners is then essential for the formation of PML NBs (80,
81).

SUMO in Developmental Processes
Studies in several model systems have demonstrated that SUMOylation is
critical developmental programs. In mitosis, specific roles for SUMO in regulating
the normal execution of the cell cycle have been described since SUMO was first
discovered two decades ago. In S. cerevisiae mutations in Uba2p or Ubc9p cause cells
to arrest at the G2/M boundary indicating that SUMOylation is necessary for
progression through the cell cycle (32, 79). Severe chromosome segregation defects
are observed in mice lacking Ubc9 (81) and S. pombe mutants lacking Aos1p
homologue (38). Several important targets of SUMOylation in mitosis have been
identified including the cohesin and condensin complexes, components of which are
known to be SUMOylated further linking SUMOylation and mitosis (reviewed in
(82)). Another critical substrate of SUMOylation during mitosis is DNA
topoisomerase II (TopII) where mutants that lack SUMOylation are unable to
undergo normal chromatid dynamics (reviewed in (36)). In yeast, SUMO E3 ligase
mutants do not display strong mitotic phenotypes (reviewed in (82)). This may be
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because E3 ligase are redundant in their function for key cellular protein, or it is
possible that Ubc9 is able to catalyze SUMO transfer during mitosis. Such regulation
of the cell cycle is not limited to the E1, E2 and E3 enzymes alone – the SUMO
protease Ulp1 has also been identified to be necessary for passage through the cell
cycle. Ulp1 mutants in budding yeast are delayed at the G2/M boundary and suffer
from increased chromosome mis-segregation (51). Deletion of Ulp2 is not lethal but
cells lacking Ulp2 lose chromosome and are hypersensitive to microtubule
destabilizing drugs (78).
During meiosis in yeast, SUMO is predominantly localized to synaptonemal
complex (SC) and Zip3 which is a SUMO E3 ligase is crucial to initiating formation of
the SC formation (84, 85). SUMO-mediated regulation of SC formation is a fairly
conserved function across sexually reproducing organisms, but is absent from
Tetrahymena. In higher eukaryotes such as mice and humans, SUMO localizes to
specific regions of the chromatin that change as meiosis progresses (86, 87)
suggesting that SUMOylation dynamically regulates proteins substrates throughout
meiosis. In Drosophila, SUMOylation has been shown to modulate several
developmental processes from wing morphogenesis, patterning of the eggshell and
embryo to neurogenesis and metamorphosis which heavily indicates that
SUMOylation is an important effector modification (reviewed in (88)). Several other
in vivo studies have highlighted the importance of SUMO and its pathway proteins,
Ubc9, PIAS and SENPs in embryonic development in numerous model systems
(reviewed in (89)).
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The SUMO Enigma
At any given time, the amount of SUMO present in the form of SUMO adducts
is lower than the free form of SUMO (90–93). In addition, SUMOylation appears to
be a transient modification due to the action of SUMO proteases and as a result,
SUMO-modified proteins do not persist in the cell for long periods of time (5, 94,
95). These challenges make it difficult to investigate SUMO and its target proteins.
The most important experiment in studying the modification of a protein by
SUMO is in the identification of the site of attachment of SUMO protein on the target
protein. While mutating the lysine residue that forms the isopeptide bond is a good
test for confirming SUMOylation state, it may negatively affect other PTMs that may
utilize the same residue. Gene knockouts, conditional mutants, overexpression and
dominant-negative studies may prove useful in studying SUMOylation but
appropriate controls have to be utilized.
Herein the use of mass spectrometry-based proteomics approach that do not
perturb the attachment sites of SUMOylation are extremely powerful and useful in
the identification and characterization of SUMO substrates that exist as a smaller set
of the total protein pool. An added advantage of these methods is the ability to
identify several proteins at one time that give more insight into the SUMOylation
state of the cell.
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Tetrahymena is a Model System for studying SUMOylation
Ciliates are unicellular organisms that are characterized by presence of cilia
on their cell surfaces and the presence of two nuclei unlike other eukaryotes. Each
ciliate cell maintains both a transcriptionally inert germ-line micronucleus (mic)
and a transcriptionally active somatic macronucleus (MAC). In the sexual life cycle,
also referred as conjugation, two cells of different mating types pair together to
initiate mating. In the early part of conjugation, the diploid mic in each partner will
undergo meiosis to form haploid gamete nuclei. A single gametic nucleus will be
transferred to another cell where it fuses with another gamete nucleus and form a
zygotic nucleus. In the later stages of conjugation, broadly classified as MAC
Differentiation, new progeny mics and MACs are derived from the zygotic nucleus
(Figure 2) with the parental MAC degraded concomitantly. The new MACs (also
termed anlagen) are derived from DNA amplification of the mic genome followed by
genomic remodeling (reviewed in (96, 97)). The first type of type of genomic
remodeling is chromosome breakage, in which the 5 chromosomes of the mic
undergo ~50 breakages to form the ~250-300 acentric polygenomic chromosomes
of the MAC. Chromosome breakage is a highly precise process with fragmentation of
the chromosomes into smaller pieces and de novo addition of telomeres to newly
broken ends (98, 99). The second type of genomic remodeling results in the
elimination of mic-limited sequences from the anlagen. These sequences called
internal eliminated sequences (IES) are removed by double-strand breaks in the
DNA with the adjacent MAC-destined DNA being ligated back together (reviewed in
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(100, 101)). It is now known that this type of DNA elimination in ciliates involves
the same process of RNA-guided heterochromatin formation required for silencing
of transposon elements in other eukaryotes (reviewed in (102, 103)).

Figure 2. The sexual life cycle of Tetrahymena. In Tetrahymena, the diploid mic is
transcriptionally silent and is responsible for germ-line functions. Conjugation
(sexual reproduction) is a complex and dynamic process that starts cells pair (1-2
hours). Following pair formation, the nuclei elongate to form “crescent” structures
(3.5 hours) and then undergo meiosis during which genetic material is exchanged
between partner cells (4-5 hours). A single meiotic product is selected for
pronuclear exchange (5.5 hours) which then undergoes two post-zygotic divisions
to generate two new mic and MACs (7 hours). The process of MAC development (7-8
hours) involves extensive genomic remodeling and DNA amplification. When cells
are returned to nutrient medium, they divide to generate daughter progeny (24-30
hours).

Tetrahymena is a useful model system for studying SUMOylation as a
developmentally regulated process because it exhibits nuclear dimorphism – there
is strong demarcation between somatic (MAC) and germ-line (mic) functions which
makes it easy to study the vegetative and sexual life cycles separately. Mechanisms
present in higher eukaryotes such as humans or other mammals that are either
absent in other eukaryotic microbial model systems, or not as readily accessible in
them as in Tetrahymena, are especially relevant. For example, lethal mutations can
be harbored in the mic of a cell with a wild-type MAC that would presumably be
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lethal in other model systems. The MAC genome has been sequenced and annotated
and is comparable to that of multicellular organisms (104–106). Switching between
the vegetative and sexual life cycles is as easy as mixing nutrient-starved cells of
different mating types together. More importantly, the precise and tight regulation
of nuclear processes that occur during conjugation provide a platform to study the
various biochemical pathways that come into play during these critical processes.
During MAC development the synchronized series of events in the new anlagen
which include programmed DNA rearrangements in the form of site-specific DNA
deletions (100, 106), de novo histone methylation (101), histone acetylation (107)
and amplification of the MAC genome (100, 108) provide a dramatic and
exaggerated series of biochemical events important in the nucleus. Genetic
manipulations in Tetrahymena offer a natural complement to phenotypical studies
for developing an overview of a pathway, and for identifying novel factors. A major
challenge in current approaches to analyzing SUMOylation as a regulatory PTM is
the low level of SUMOylated proteins (see The SUMO Enigma section above). The
reasons for developing such a system in Tetrahymena are obvious - there are many
model systems available for investigating the role of SUMOylation, however, few of
them are amenable to studying the role of this PTM as they lack distinct
developmental stages. An examination of the dynamic SUMOylation of substrates
during these stages will reveal the role of low-level participating proteins. In this
way, it will be possible to build functional links between the numerous substrates of
Smt3p and the various developmental processes. We are interested in elucidating
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the mechanism by which SUMOylation regulates programmed DNA rearrangements
in the form of IES excision. The removal of these elements occurs in quite the
dramatic fashion with approximately 6000 IES elements being excised followed by
repair of resulting double strand breaks. This exaggerated phenomenon of IES
excision occurs naturally as part of sexual life cycle of Tetrahymena and therefore
provides a tremendous opportunity in studying the regulation of this process by
SUMOylation. There are very few published studies that document the broad
spectrum of proteins, involved in critical cellular processes, that are SUMOylated in
response to different life cycles and herein Tetrahymena proves its versatility as a
facile genetic model system.
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CHAPTER 2 – SUMOYLATION IS DEVELOPMENTALLY REGULATED AND REQUIRED
FOR CELL PAIRING DURING CONJUGATION IN TETRAHYMENA
Genetic analysis has revealed essential roles for SMT3 in the survival and
development of organisms ranging in complexity from lower eukaryotes such as
yeast to mammals. Studies of the loss of SUMOylation components function reﬂect
the impact of SUMOylation on entire organisms. Mutants for SMT3 (SUMO), UBA2 as
well as UBC9 have been reported for most developmental models from yeast and C.
elegans to mouse. Although different phenotypes have been described for different
species, these studies have demonstrated that components of the SUMOylation
pathway are essential genes in these organisms. In S. cerevisiae, there is an absolute
requirement for SMT3 in cell viability (33, 109). Deletion of SUMO pathway genes in
the nematode C. elegans results in embryonic lethality, while downregulating the
expression of SUMO conjugating enzyme Ubc9 in Drosophila, zebrafish, and mouse
results in serious developmental defects (48, 81, 110).
The Tetrahymena genome encodes a single form of SUMO (referred to as
SMT3; Table 1) (111), which shares 49% and 48% sequence identity with human
SUMO-1 and SUMO-2, respectively. SMT3 appears to have diverse roles inside the
cell including, but not limited to, regulation of transcription, protein translation,
DNA repair response, mitosis and meiosis etc. While SMT3 is present throughout the
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two life cycles of Tetrahymena, cells undergoing MAC development during
conjugation contain particularly high concentrations of Smt3p (112), suggesting
that SUMOylation may play particularly critical roles at this stage of Tetrahymena
development.
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Materials and Methods
Strains and Culture Conditions
Wild-type B2086 and CU428 strains of Tetrahymena thermophila were
obtained from the Tetrahymena Stock Center, Cornell University, Ithaca, New York,
USA. Strain B2086 contains 6-methly purine sensitive (MPR1) wild-type MACs with
expression of mating type II. Strain CU428 contains 6-methyl purine sensitive
(MPR1) wild-type MACs with expression of mating VII but contain micronuclei that
have homozygous 6-methyl purine resistance (mpr1-1/mpr1-1). Wild-type and all
other Tetrahymena strains were cultured in 1×SPP medium (2% proteose peptone,
0.1% yeast extract, 0.2% glucose and 0.003% FeCl3) at 30 °C with shaking at 110
rpm for vegetative growth. Smaller volumes (1-10 mL) did not require shaking.

Mating Tetrahymena
For conjugation, T. thermophila strains were placed at 30 °C in 1×SPP and
allowed to grow to logarithmic phase with an O.D.540 of 0.3 corresponding to 2×105
cells/mL. Cells were then washed with Starvation Buffer (10 mM Tris, pH 7.5) and
then subsequently starved (16-24 hours at 30 °C) in 10 mM Tris (pH 7.5). Equal
numbers of cells of different mating types were mixed together to initiate mating.

Construction of SMT3 and UBA2 germ-line knockout
The targeting construct consisted of a neo3 cassette conferring paromomycin
(pm) resistance placed under the control of the metallothionein (MTT1) promoter
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(113). The drug resistance gene is flanked by sequences upstream and downstream
of the SMT3 (5’ flank sequence was 1141 bp; 187801 to 188942 bp of scaffold
8254555 and 3’ flank sequence was 1292 bp; 190002 to 191294 bp of scaffold
8254555) or UBA2 coding sequence (5’ flank sequence was 1004 bp; 472623 to
473627 bp of scaffold 8254719 and 3’ flank sequence was 1148 bp; 476286 to
477434 bp of scaffold 8254719) (primers listed in Appendix Table 6). Wild-type
B2086 and CU428 strains were then mated and the targeting construct was
introduced at 2.5-3.5 hours post-mixing as described (114). Potential SMT3 and
UBA2 micronuclear knock-out (KO) strains were identified by selection with
paromomycin (confirming insertion of the neo3 cassette) and 6-methyl purine
(6mp; confirming successful conjugation and formation of new macronuclei). The
heterozygous mic KO strains were further analyzed by PCR and genetic crosses to
test strains (e.g. CU427) to confirm germ-line segregation of paromomycin
resistance. These heterozygous germ-line transformants were crossed with “star”
strains B*VI and B*VII that are deficient in donating a functional micronucleus. The
subsequent uniparental transfer that occurs resulted in the generation of
homozygous germ-line knockout heterokaryon strains (115). The micronuclei
(germ-line) in these cells have homozygous deletions of the targeted gene, but the
MAC genome is wild-type because the two partners of “star” crosses do not proceed
through conjugation to form new MACs. PCR analysis as well as genetic crosses
confirmed the genotype of each KO heterokaryon (see Table 2 and Figure 6).
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Viability Test
To test the viability of the progeny of SMT3 or UBA2 homozygous
heterokaryons strains, starved SMT3 or UBA2 heterokaryons strains (~2×105
cells/mL) were mixed to initiate mating and mating efficiency was assessed at 2
hours. Mating pairs were then isolated at 8-10 hours post-mixing in drops
containing 1×SPP medium and placed at 30 °C. Cells in drops were examined at
multiple times between 24 and 72 hours post-mixing. The number of cell divisions
that occurred before death of homozygous SMT3 and UBA2 KO progeny was
calculated by counting the total number of cells at the time of death, dividing by two
(two exconjugants per pair) and calculating the cell divisions based on exponential
growth. To determine successful completion of conjugation in SMT3 or UBA2
heterokaryons, cells were cultured in 1×SPP containing 80 μg/mL paromomycin.
Progeny of control cell lines wild-type B2086.2 × CU428.1 were also tested for 6methylpurine (7.4 μg/mL) resistance. Additional matings between SMT3 and UBA2
heterokaryons to wild-type partners were also performed to ensure generation of
viable progeny (Table 2). To check for progression through conjugation, cells were
fixed and stained with DNA-specific dye diamidinophenolindole (DAPI) as described
below (see Fluorescent and Confocal Microscopy).

Creation of GFP-SMT3 and GFP-UBA2 constructs
To examine Smt3p and Uba2p localization in Tetrahymena, coding regions for
Smt3p and Uba2p were amplified and cloned into the pENTR/D-TOPO plasmid

31

(Invitrogen, Grand Island, NY), which is used for recombination with the Gateway
cloning system, to create pENTR-SMT3 and pENTR-UBA2 respectively. LR Clonase II
(Invitrogen, Grand Island, NY) was used for directional cloning of SMT3 or UBA2 into
the destination vector pBSmttGFPgtw containing an N-terminal MTT1-inducible GFP
expression cassette cloned upstream of a cycloheximide-resistant Tetrahymena
rpl29 locus (described in (116)). For biolistic transformation, constructs were
digested with HindIII or BlpI to produce linear plasmid with flanking rpl29
sequences and transformed into starved Tetrahymena cells. Transformed cells were
selected in SPP nutrient medium containing 12.5 μg/mL cycloheximide. To induce
GFP-SMT3 or GFP-UBA2 expression, 0.1 μg/mL CdCl2 was added to vegetative and
mitotic cells. For mating cells, 0.05 μg/mL CdCl2 was added when cells were first
mixed and at 6 hours post-mixing. Cells were fixed as described below (see
Fluorescent and confocal microscopy).

Fluorescent and Confocal Microscopy
GFP-SMT3 or GFP-UBA2 expressing cells were fixed with 4%
paraformaldehyde for 30 minutes at room temperature, then washed with 1×Trisbuffered Saline (TBS; 0.5 M Tris-Cl, 1.5 M NaCl, pH 7.6) for 10 minutes and stained
with the DAPI at 1 μg/mL for 10 minutes. DAPI-stained cells were then placed on
microscope slides and 5 µL of VectaShield Fluorescence Mounting Medium was
applied to the cells. Fluorescent microscopy of vegetative strains expressing GFP
transgenes (Figure 1) was performed using a Zeiss LSM 710 confocal microscope.
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Digital images were processed using Zen 2009 (Carl Zeiss, Thornwood, NY) and
Adobe Photoshop (Adobe Systems, Inc., San Jose, CA). Fluorescence images of mated
cells (Figure 3) were obtained with an Olympus BX51TF model microscope and a
40X objective oil lens (UIS2/BFP1; Olympus).

Generating Conditional Mutants of SMT3 and UBA2
UBA2 knockout heterokaryons of different mating types were mixed with
each other to initiate mating. Cells undergoing MAC development (corresponding to
8 hours post-mixing) were biolistically transformed using the MTT1 promoter
expressed GFP-UBA2 transgene inserted at the rpl29 locus (cycloheximide
resistance). Progeny that were successfully transformed (paromomycin resistant
and cycloheximide resistant) were complete gene knockouts for wild-type UBA2 and
expressed only the GFP-UBA2 form. SMT3 heterokaryons that were mated died in
the first 24 hours after conjugation and we were unable to rescue cells using GFPSMT3 as described above. To generate a conditional mutant of SMT3, CU522 and
CU527 strains that are sensitive to the drug paclitaxel (taxol; txs) were transformed
with MTTp driven FLAG-His6-SMT3 construct (gift of Dr. Joshua Smith, Missouri
State University) which was incorporated at the BTU1 locus resulting in progeny
that are taxol-resistant (method originally described in (117)). FLAG-His6-SMT3
expressing strains were further transformed with the neo3 construct used earlier to
generate SMT3 KO heterokaryons. Cells were cultured in increasing concentrations
of taxol and paromomycin to assort for FLAG-His6-SMT3 copies and the reduction of

33

wild-type SMT3. Complete assortment of the wild-type SMT3 gene away from the
FLAG-His6-SMT3 copy was demonstrated by performing two-step Reverse
Transcriptase-PCR (RT-PCR) on RNA obtained from FLAG-His6-SMT3 expressing
strains which showed amplification of the FLAG-His6-SMT3 product only.

Assessment of Pair Formation
To assess pair formation, conditional mutants of SMT3 or UBA2 were
cultured using three different conditions. The “+Cd” cultures were grown in SPP
medium supplemented with 0.1 µg/mL CdCl2 for 24 hours at 30 °C. These cells were
then starved in Starvation Buffer containing 0.1 µg/mL CdCl2 for 24 hours at 30 °C
after which they were mixed to initiate mating pair formation. The “−Cd” cultures
were grown and starved in the absence of CdCl2 and then mated to assess pair
formation. The “+Cd Addition” cultures, were treated as described for the “−Cd” set
except that 2 hours prior to mixing, cells were supplemented with 0.1 µg/mL CdCl2
and then mated. The percentage of cells forming pairs was calculated as the number
of cells in pairs divided by the total number of cells in the sample (paired plus single
cells).

Preparation of Whole Cell Extracts
100 mL of vegetative wild-type strains B2086.2 and CU428.1 at log-phase
(2×105 cells/mL) and mated cells (at 0, 2, 5, 7, 10, 24, and 30 hours post-mixing,)
were harvested by centrifugation, washed twice with Starvation Buffer (10 mM Tris-
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Cl, pH 7.5) and then resuspended in 2 mL of lysis buffer (8 M Urea, 50 mM Tris, pH
8.0) containing 50 mM N-ethylmaleimide and lysed by sonication. The resulting
lysate was centrifuged at 4 °C for 30 min at 77,000×g in a SW41 rotor (Beckman
Coulter). The clarified supernatant was then prepared for Western Blotting as
described below.

Western Blotting and Coomassie Staining Analyses
Clarified lysates from wild-type strains were prepared by the addition of SDS
loading buffer to a final concentration of 1× (50 mM Tris, pH 6.8, 10% glycerol, 2%
SDS, 100 mM DTT, and 0.05% bromophenol blue). Samples were separated on 8%
Bis-Tris Gels using Tris Glycine SDS running buffer and then transferred to PVDF
membrane (Pall Corporation, Port Washington, NY) at 100 V for 2 h. Subsequent
Western blot analysis was then performed with anti-Smt3p and horseradish
peroxidase-conjugated secondary antibodies (Jackson Immunoresearch, West
Grove, PA). Smt3p antibodies were custom generated by ProteinTech Group Inc.
(Chicago, IL). Rabbits were immunized with a peptide corresponding to amino acids
26-43 of Tetrahymena Smt3p (FFKIKKTTQFKKLMDAYC) and then antibodies were
affinity purified from the resulting serum using the same peptide. Results were
visualized with the ECL Prime chemiluminescence detection system (Amersham
Biosciences, Piscataway, NJ). Coomassie staining was performed by first treating the
SDS gel with fixing solution (10% glacial acetic acid and 25% isopropanol) for 3
hours and then incubating it in Coomassie R250 staining solution (0.05% Coomassie
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R250, 10% acetic acid and 25% methanol) overnight at room temperature.
Destaining was done in 10% glacial acetic acid for 3 hours.
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Results
Tetrahymena Smt3p and Uba2p primarily accumulate in the macronucleus
Previous studies on Paramecium tetraurelia revealed that RNAi induced
silencing of UBA2 or SUMO resulted in the failure of programmed DNA
rearrangements (111), but the underlying mechanism responsible for this effect was
not established. Tetrahymena was selected for additional studies because of
technical advantages (gene knockouts, higher mating efficiency) and the
opportunity for comparative analysis with Paramecium. To initiate our analysis of
SUMOylation we searched the Tetrahymena thermophila genome for homologs and
identified a single gene encoding SUMO (118) with reciprocal top BLAST hits to
SUMO proteins in S. cerevisiae, Drosophila and human. We named the Tetrahymena
gene SMT3 (TTHERM_00410130) (111), consistent with S. cerevisiae nomenclature
(Suppressor of Mif Two 3) (Table 1). The alignment of Tetrahymena Smt3p with
human SUMO isoforms, S. cerevisiae, S. pombe and other protozoa is shown in Figure
3A. Tetrahymena Smt3p shares 50% identity with S. cerevisiae. The N-terminal
regions show substantial divergence, but most of the protein is highly conserved
including the diglycine motif conserved in the C-terminus of most UBLs. A
Tetrahymena homolog for UBA2 was previously reported based on its identity with
Paramecium tetraurelia (TTHERM_00391590) (111). That study evaluated the
developmental expression of transcripts from the Tetrahymena UBA2 and SMT3
(SUMO) genes with northern hybridizations. Both showed substantial increases in
expression during sexual reproduction, consistent with subsequent data from whole
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genome microarrays (40). The developmental pattern of expression and sequence
identity between these genes when compared with the previously examined
Paramecium UBA2 and SUMO genes led us to perform additional studies.
To evaluate whether the cellular location of Tetrahymena SUMOylation
pathway proteins is consistent with Paramecium tetraurelia and other eukaryotes,
we examined the localization of Smt3p and Uba2p. Localization of Smt3p and Uba2p
during vegetative growth was examined by expressing GFP-SMT3 or GFP-UBA2
transgenes from a metallothionein promoter regulated by cadmium. Both Smt3p
and Uba2p were observed in the somatic MAC but not the germ-line mic in
vegetative Tetrahymena (Figure 3B). Based on the coding sequence of SMT3, we
generated rabbit polyclonal anti-Smt3p antibodies by immunizing animals with
residues 21-43 of the full-length Tetrahymena Smt3p protein and used them to
examine localization of Smt3p in vegetative cells (described in Materials and
Methods). As seen in Figure 3C the predominant signal is in the macronucleus and
no signal can be detected in the micronucleus. The signal at the cell cortex was
detected with secondary antibody alone (no primary antibody) and is therefore
unlikely to be significant. Additional experiments with the GFP transgenes showed
that increasing or decreasing cadmium concentrations changed the strength of the
GFP signal but did not alter its nuclear localization (data not shown). Although a
small fraction of Uba2p and Smt3p are likely present in the cytoplasm we are
confident that the signal is predominantly macronuclear in vegetative cells. Studies
of other developmental model systems such as mice (22, 23), Drosophila (24, 25)
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and yeast (26) have reported that both Smt3p and Uba2p localize predominantly to
the nucleus. This is expected as many of the proteins modified by SUMO are nuclear,
including promoter-specific transcription factors, DNA repair proteins and
chromatin-associated proteins. Our results in Tetrahymena are consistent with the
role of SUMOylation in somatic nuclear processes such as the regulation of
transcription, which is limited to the MAC in vegetative cells.
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Figure 3. Smt3p localizes to the somatic MAC during vegetative growth. (A)
Sequence alignment of Smt3p isoforms from 7 species. Dark shading represents
residues with highest percent identity across all sequences. Light shading indicates
less conserved residues. The sequences and the accession numbers of Smt3p are as
follows: H. sapiens SUMO-1, NP_003343.1; H. sapiens SUMO-2, NP_008868.3; H.
sapiens SUMO-3, NP_008867.2; S. cerevisiae, NP_010798.1; S. pombe, NP_596035.1;
P. falciparum, PFE0285c in PlasmoDB; O. trifallax, Contig18025.0.g12 in
OxytrichaDB; P. tetraurelia, GSPATG00013187001 in ParameciumDB; and T.
thermophila, TTHERM_00410130 in Tetrahymena Genome Database. (B) Nuclear
localization of Smt3p and Uba2p during vegetative growth. GFP-SMT3 and GFP-UBA2
constructs were transcribed from the metallothionein 1 promoter upon addition of
cadmium. The GFP signal prominently localized in the somatic MAC but was absent
from the germ-line mic (inset for the GFP-UBA2 is shown). (C) Immunofluorescence
of log-phase wild-type cells treated with Tetrahymena polyclonal anti-Smt3p
antibodies show that the signal is predominantly macronuclear. Cortical staining
was observed in pre-immune controls (data not shown). Arrow-heads indicate MAC
and arrows indicate the position of the mic.
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SUMOylation increases during conjugation in T. thermophila
Anti-Smt3p antibodies used in Figure 3C were also utilized to determine
SUMO expression throughout conjugation by western blot analysis. Figure 4A shows
schematic representations of the stages when protein was prepared for analysis.
Figure 4B shows a typical SUMOylation pattern with several reactive bands
consistent with a range of proteins conjugated to Smt3p. The image is a short
exposure to emphasize the difference in signal between vegetative cells and
conjugating cells, but longer exposure show a large number of bands in the
vegetative protein samples. The arrow head labeled Smt3p indicates the expected
migration of free Smt3p. Experiments with high percentage gels (20%) showed that
Smt3p migrates with a mass of approximately 13.5 kDa, but on the 10% gel shown
in Figure 4B proteins below 20 kDa are not well resolved. A slightly higher apparent
molecular mass than the theoretical molecular mass (11.4 kDa) of Smt3p is not
surprising as SUMO proteins have been reported to exhibit anomalously slow
migration on SDS-PAGE gels (1). The high molecular mass bands observed at the 40200 kDa range are Smt3p substrates that represent a diverse set of target proteins
that are modified by Smt3p in vegetative and mating cells. In mating cells, we
observed that Smt3p adduct formation increases as cells progress through
conjugation with the highest signal observed between 7 and 10 hours post-mixing
which corresponds to anlagen formation implicating SUMOylation in its role in MAC
differentiation (Figure 4A and 4B). The bar graph in Figure 4C provides a
quantitative assessment of the increased signal above 40 kDa relative to total
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protein as measured by Coomassie staining. This increase in Smt3p signal is
consistent with microarray expression data, which shows an increase in transcript
levels during conjugation including anlagen formation (40). These results
demonstrate that SUMOylation occurs differentially between vegetative and mating
Tetrahymena with a peak in SUMO conjugates observed during MAC differentiation.
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Figure 4. Differential modification of proteins by Smt3p during conjugation versus
vegetative growth. (A) Schematic representation of the stages of conjugation at
which cells were lysed. The following stages are shown: Pair Formation; Pronuclear
Exchange; MAC Differentiation; Anlagen Formation; and Exconjugants. (B) Whole
cell extracts (WCEs) were prepared from vegetative and mating B2086 and CU428
wild-type cells at 0, 2, 5, 7, 10, 24, and 30 hours post-mixing. WCEs were analyzed
by 10% SDS-polyacrylamide gel electrophoresis followed by Coomassie blue
staining (for loading control; bottom panel) and Western blot using polyclonal antiSmt3p antibody (top panel). Arrow-head indicates the expected position of free
Smt3p (~13 kDa) and high molecular weight proteins that are likely to be Smt3p
conjugates. Coomassie stained gel is included as a control to evaluate equivalent
sample loading. (C) The bar graph provides a quantitative assessment of the
immunoblot signal across different time points after normalizing for sample loading
(Coomassie stained gel).

43

To determine the cellular location of the increased Smt3p we performed
immunofluorescence with the same anti-Smt3p antibody used in Figure 4. Mating
cells were fixed at various times during conjugation leading up to the beginning of
MAC development (9 hr). A low signal relative to background fluorescence masked
specific localization in early stages of conjugation. As conjugation progressed, Smt3p
was detected in parental MACs by the end of meiosis, and the antibody revealed a
strong accumulation in the developing anlagen (Figure 5). We also used the GFPSmt3p expressing strains (described in Figure 1) and found that Smt3p first
localized to parental MACs early in conjugation and later accumulated in the
developing anlagen which mimicked our results with the anti-Smt3p
immunofluorescence analysis (Figure 5). Both techniques showed that the signal in
the parental MAC disappeared as the anlagen developed and before the MAC was
degraded. We did not detect Smt3p in the micronuclei or meiotic products during
conjugation using anti-Smt3p or GFP-Smt3p. Although the GFP-Smt3p strains have
the disadvantage of expression from the inducible MTT1 promoter, the consistent
results using antibodies and GFP fusions give us confidence in our observations.
In Paramecium GFP-Uba2p localized to the developing MAC (111).
Antibodies against Tetrahymena Uba2p are not available for immunofluorescence,
but GFP-Uba2p was expressed from the inducible MTT1 promoter in the absence of
wild-type Uba2p (described in Materials and Methods). As shown in Figure 3, GFPUba2p is located in the old MAC during the meiotic “crescent” phase (prophase I) of
conjugation. The signal remains in the old MAC at later stages of meiosis and unlike
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Smt3p, Uba2p is clearly visible in the meiotic products labeled “meiotic haploid
products” in Figure 5. The signal is also detectable in haploid products during the
period of pronuclear exchange (Figure 5). As the developing MAC (anlagen) appear
they contain increasing Uba2p signal and the signal is simultaneously reduced in the
parental (old) MAC. Consistent with our observations in vegetative cells, the signal
is not detected in micronuclei at the two mic two MAC stage of development.
Interestingly, Paramecium GFP-Uba2 expressed from its endogenous promoter
showed little signal in the parental MAC and the primary signal appeared in the
anlagen (111). The Tetrahymena Uba2p and Smt3p localization results (Figure 5)
along with the immunoblot (Figure 4) are consistent with a major increase in
SUMOylation of nuclear proteins during conjugation, particularly in the developing
MAC. The absence of GFP-Smt3p localization in the meiotic products in contrast to
the GFP-Uba2p localization to those structures is not readily explained, but it is
clearly not an issue of protein abundance (the result was independent of the level of
expression) or stability (since the signal in the MAC was robust).
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Figure 5. Localization of Uba2p and Smt3p in conjugation. UBA2 deletion cells were
rescued with the MTT1-driven GFP-UBA2 construct to generate N-terminally tagged
GFP-Uba2p expressing cells. Cells were mated and then fixed and stained with DAPI
at various times throughout conjugation. GFP images were taken to visualize the
distribution of UBA2 in mating pairs. GFP-SMT3 was transformed into B2086 and
CU428 wild-type strains to produce N-terminal GFP-Smt3p tagged strains. The GFPSmt3p expressing strains were mated and fixed at time-points shown in the figure.
Smt3p localization was also visualized in mated wild-type cells using anti-Smt3p
antibodies. A schematic of nuclear morphologies as observed in wild-type mating is
drawn for reference. The following developmental stages are observed: “crescent”
micronuclei (prophase meiosis I) (4 hr); meiotic haploid products generated after
completion of meiosis II (5 hr); pronuclear differentiation and exchange (6 hr);
second post-zygotic mitosis (7 hr); and macronuclear anlagen formation and
nuclear processing (9 hr). Arrow-heads indicate selected anlagen, arrows indicate
selected mic.

Complete Deletions of SMT3 and UBA2 Result in Cell Lethality
In budding yeast and invertebrates such as the nematode Caenorhabditis
elegans, there is a single SMT3 gene which is essential for viability (28, 29).
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Deletions in the SUMO-activating enzyme UBA2 or the SUMO-conjugating enzyme
UBC9 are lethal in the budding yeast (32, 33, 79), C. elegans (119), A. thaliana (120)
and in mouse (81). In Paramecium tetraurelia, RNAi silencing of UBA2 or SUMO had
no detectable effect on vegetative cells but arrested conjugating cells. To test
whether SMT3 and UBA2 are essential genes in Tetrahymena, we generated
micronuclear (germ-line) deletion strains that were subsequently mated to produce
complete (mic and MAC) deletions. The initial heterozygous mic knockout strains
were selected with paromomycin after transformation with knockout (KO)
constructs containing the neomycin resistance cassette (neo3) flanked by sequences
upstream and downstream of each coding regions (Figure 6A). The resulting
heterozygous knockout cells were cultured without paromomycin selection to allow
phenotypic assortment of the drug resistant (KO) alleles and identification of
paromomycin sensitive cells with fully wild-type MACs. These heterozygous
knockout cells were mated with “star” strains containing defective micronuclei and
wild-type MACs. These crosses result in abortive conjugation, in which paired cells
complete meiosis and exchange genetic material, but separate without making new
macronuclei. These post-conjugation cells emerge with homozygous micronuclei,
but retain their original MACs genetically wild-type for SMT3 and UBA2 (Figure 6A
and 6B) (115). Phenotypically these cell lines are paromomycin sensitive, but we
used PCR amplification to identify the strains homozygous for the neo3 cassette in
place of the corresponding coding region in the micronucleus (Figure 6C). These
homozygous heterokaryon knockout strains of SMT3 or UBA2 were then mated and
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individual pairs were isolated to nutrient medium. Analysis of >100 pairs from each
cross revealed that the majority of pairs failed to survive (Table 2). Pairs that did
survive were tested for paromomycin-resistance to determine whether they were
true exconjugant progeny or pairs that aborted conjugation. This test was used
because the parental strains were phenotypically paromomycin-sensitive (MAC
genotype) but their germ-line micronuclei were homozygous for paromomycin
resistance. The formation of a new MAC would result in paromomycin resistance. As
indicated in Table 2, none of the surviving lines were paromomycin resistant and
most likely they were abortive mating pairs containing wild-type MACs. Control
crosses of the same knockout heterokaryon strains with wild-type cells (B2086 or
CU428) resulted in high survival (~93 %) of true exconjugant progeny that were
paromomycin resistant. This demonstrates that the knockout heterokaryons contain
fertile micronuclei. The data are consistent with a lethal phenotype for complete
deletions of SMT3 or UBA2. This has been reported in other organisms and we
conclude that both are essential genes in Tetrahymena.
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Figure 6. Generation of SMT3 and UBA2 knockout heterokaryons. (A) Schematic
drawings of SMT3 and UBA2, their targeted loci, the knockout construct as well as
the resulting gene knockout formed by homologous recombination. The entire SMT3
and UBA2 coding sequences were replaced by insertion of the neo3 knockout
cassette that confers paromomycin resistance. Arrows indicate the locations of
primers used for genotyping PCR from total DNA. (B) To generate Tetrahymena with
homozygous deletions in the mic, a type of abortive mating called round I genomic
exclusion was utilized wherein wild-type cells were crossed with ‘star’ strains that
have defective micronuclei. Star strains are able to form mating pairs with wild-type
cells but do not provide a migratory gametic micronucleus to the wild-type partner
following meiosis. The single haploid micronucleus that is donated by the wild-type
partner to the star partner, then undergoes endoreplication, to form a homozygous,
diploid micronucleus in each conjugant. At this point, the mating pair aborts
conjugation and separates. (C) Total DNA isolated from wild-type CU428 (lane 6),
SMT3 (lanes 1-4; top panel) and UBA2 (lanes 1-4; bottom panel) knockout
homozygous heterokaryons was PCR amplified with primers shown in (A). Positions
of the bands for the disrupted (KO) loci as well as wt genes are indicated. Genotypes
of SMT3 and UBA2 homozygous germ-line knockout heterokaryon strains and wildtype strains are illustrated at the top. Lane 5 in both gels contained the
corresponding KO construct as template.
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Interestingly, there was a substantial difference in the timing of postconjugation death for ΔSMT3 and ΔUBA2 strains. ΔSMT3 progeny died before the
first post-zygotic cell division, but ΔUBA2 progeny died much later, 6-8 cell divisions
after mating (~72 hours post-isolation). Clearly UBA2 expression is not required
from the zygotic macronucleus (anlagen) to complete conjugation. The SMT3 and
UBA2 knockout heterokaryon crosses were monitored by DAPI staining to detect
any grossly aberrant nuclear events (i.e. meiosis, pronuclear fusion, mitotic
divisions and anlagen development), but none were detected. The ΔUBA2 vegetative
progeny have the normal distribution of 1 MAC and 1 mic prior to death. The ΔSMT3
progeny arrest in conjugation at the 2 MAC, 2 mic stage, but the events prior to that
appear normal (data not shown). We also examined the ΔSMT3 progeny and ΔUBA2
progeny for defective programmed DNA elimination. Using a PCR strategy
developed previously (116) we examined DNA from cells at the time of mixing (time
0) and 24 hours later from several hundred conjugating pairs collected after mixing
the same culture. A total of five eliminated DNA elements were examined for each
cross. The results for the M and R elements in ΔSMT3 progeny are shown in
Appendix Figure 15. For each eliminated element the product expected for accurate
DNA processing was detected and there was no evidence for the inhibition of DNA
elimination. The explanation for the shorter life span of ΔSMT3 cells compared with
ΔUBA2 is not clear but could result from faster depletion of parentally expressed
Smt3p.
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Table 2. SMT3 and UBA2 are essential genes.
No.
No. wells
No. of clones
individual
with
more
a
completed
Types of mating cells
pairs
than 2
b
conjugation
examined
cells/drop
ΔSMT3-neo3-1 × ΔSMT3-neo3-2
110
34
0
ΔUBA2-neo3-1 × ΔUBA2-neo3-2
124
32
0
ΔSMT3-neo3-1 × B2086
110
91
81
ΔUBA2-neo3-1 × B2086
110
96
88
ΔSMT3-neo3-2 × CU428
110
89
84
ΔUBA2-neo3-2 × CU428
110
92
83
B2086 × CU428
88
82
82
aEach row represents data obtained in the course of three independent experiments.
bTo

distinguish between cells that completed conjugation (progeny cells) and cells
that have aborted conjugation, wild-type B2086 and CU428 strains were tested for
resistance with 6-methyl purine (only progeny cells should be resistant) and cells
from the ΔSMT3-neo3 × ΔSMT3-neo3 and ΔUBA2-neo3 × ΔUBA2-neo3 mating were
checked for paromomycin resistance (progeny should be paromomycin resistant).

Gene Rescue with MTT1 Promoter Converts the SMT3 or UBA2 Deletion Lines into
Conditional Mutants
As SMT3 and UBA2 are essential genes, complete deletions resulted in cell
death making it difficult to obtain information on the null phenotype of these genes.
This problem was circumvented by the creation of conditional mutants of SMT3 and
UBA2 in which the expression of these genes could be regulated by addition of CdCl2
to culture medium. As ΔUBA2 progeny survive for up to 72 hours post-mixing, the
parental UBA2 heterokaryons were mated en masse and at 8 hours post-mixing
(corresponding to formation of new anlagen), mating cells were biolistically
transformed with the GFP-UBA2 construct (placed under MTT1 control) to rescue
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the lethal phenotype (Figure 7A). The only expressed functional copy of the UBA2
gene in these cells was the GFP-UBA2 transgene under MTT1 control. For ΔSMT3
mated cells, we were unable to rescue the lethal progeny with the GFP-SMT3
transgene, possibly due to insufficient expression of the introduced copies at the
end of conjugation. To bypass this issue, we generated Tetrahymena cell lines that
were somatic transformants expressing introduced FLAG-His6 epitope tagged SMT3
(also driven by the MTT1 promoter) at the BTU1 locus in CU522 and CU725 strains.
Incorporation at the BTU1 locus in these strains confers resistance against the drug
taxol (paclitaxel) that are otherwise taxol-sensitive. Next, we transformed these
FLAG-His6-SMT3 expressing strains with the neo3 knockout construct that replaces
the endogenous SMT3 gene and then cultured cells in increasing concentrations of
paromomycin and taxol to select for cells in which wild-type copies of SMT3 had
been assorted out and only FLAG-His6-SMT3 remained as the functional copy
(Figure 7B and C). Reverse transcription PCR was used to confirm the absence of the
wild-type SMT3 transcript (Figure 7C). To determine whether placing SMT3 and
UBA2 under the control of the MTT1 promoter would lead to a conditional, Cdregulated mutant, we examined the growth rates of these cell lines compared to that
of wild-type strains. The growth rate of the conditional strains is similar to that of
wild-type cells when the culture medium is supplemented with cadmium, but
significantly slower when these strains are cultured in cadmium-free medium
(Figure 7A and B). The difference between the lethal phenotype of the complete
gene deletion strains and the slow growth phenotype of the conditional cell lines in
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the absence of cadmium can be explained by “leaky” expression of the MTT1
promoter even in the absence of cadmium. This has been reported previously (113)
and we have seen this in our own analysis of MTT1 promoter constructs. These
results demonstrate a conditional phenotype in the absence of CdCl2 that is
consistent with Smt3p and Uba2p depletion.
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Figure 7. Tetrahymena expressing the GFP-UBA2 or FLAG-His6-SMT3 transgene
regulated by the MTT1 promoter behave as conditional mutants. (A) Schematic
drawing of ΔUBA2 homozygous heterokaryon strains that were mated and
transformed with the GFP-UBA2 transgene regulated by the MTT1 promoter and
inserted at the rpl29 locus. The resulting UBA2 conditional cell lines and wild-type
CU428 strains were grown vegetatively and transferred into 10 mL of SPP medium
at an initial concentration of 200 cells/mL with either 0.1 μg/mL cadmium or no
cadmium. At 0, 4, 8, 12, 20, 24, and 48 hours after placement in growth medium,
cells were fixed and scored using a hemocytometer. (B) ΔSMT3 homozygous
homokaryon progeny were lethal within 24 hours. Schematic drawing shows the
transformation of CU522 strain with MTT1-FLAG-His6-SMT3 at the BTU1 locus. The
same strain was then transformed with the neo3 knockout construct (MTT1
promoter) disrupting the endogenous SMT3 gene. These conditional SMT3 cells
were scored for growth as described in (A) above. (C) RT-PCR reactions to detect wt
SMT3 transcripts in conditional mutants. The locations of the primers (arrows) used
to amplify regions from the cDNA are shown on the left. Lanes 1, 2, and 3, on the gel
correspond to PCR reactions using the primer sets (1, 2, and 3) indicated on the
diagrams to the left. No wt SMT3 transcript is detected in the SMT3 conditional
mutant cell line.
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SMT3 and UBA2 requirement in mating pair formation in conjugating cells
We know from previous studies in Paramecium tetraurelia that silencing UBA2
results in conjugation arrest during MAC development (111). Using our conditional
Smt3p and Uba2p cell lines we tested the effect of Smt3p or Uba2p depletion on
conjugation in Tetrahymena. Conditional mutants of different mating types were
cultured overnight in nutrient medium with or without cadmium to either promote
or reduce expression of SMT3 or UBA2 transgenes respectively. Each culture was
washed and cultured in starvation buffer for 24 hours under the same plus (+Cd) or
minus cadmium (−Cd) conditions. Two hours before mating, 0.1 µg/mL of cadmium
was added to a flask containing a portion of the cadmium free culture (referred to as
“+Cd Addition” cells). Wild-type cells were carried through the same procedure
under the same conditions. Cells from cadmium and non-cadmium treated cultures
were mated separately. Cells were evaluated at 2 hours and 8 hours post-mixing for
pair formation and cell samples were DAPI stained to examine the nuclear events
during conjugation. Smt3p and Uba2p conditional mutant cultures that had not been
exposed to cadmium were unable to form mating pairs (Figure 8). In contrast, the
conditional mutants that had been exposed to cadmium had greater than 70% pair
formation and progressed normally through the nuclear events of conjugation (data
not shown). Smt3p and Uba2p conditional cells that were cultured without
cadmium, but treated with cadmium two hours prior to mating were able to form
pairs and progress through the normal nuclear events of conjugation as assayed by
DAPI staining (Figure 16). The finding that conditional cells can recover their ability
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to pair clearly demonstrates a dependence on Smt3p and Uba2p expression
immediately prior to conjugation, and eliminates the possibility that cells do not
pair as a result of defective nuclei or other damage that could occur during
vegetative growth. Wild-type control cells, both cadmium and non-cadmium treated,
showed greater than 80% pairing and normal progress through conjugation as
expected (Figure 8). The non-pairing phenotype of Uba2p and Smt3p depleted cells
was unexpected and prevents the use of these cell lines to examine later stages of
conjugation. Nevertheless, the elevated expression of SUMO pathway proteins and
increased SUMOylation during MAC development make additional critical functions
likely.
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Figure 8. Depletion of Smt3p and Uba2p results in inability to form mating pairs. (A)
Work flow for assaying formation of mating pairs in SMT3 and UBA2 conditional
mutants. Strains of different mating types for each genotype were cultured with
(+Cd) or without (–Cd) cadmium to early log-phase, then starved in Starvation
Buffer with the corresponding plus or minus cadmium condition (see Materials and
Methods for details). A portion of each –Cd culture was supplemented with 0.1
μg/mL cadmium two hours prior to mating, these cultures are referred to as “+Cd
Addition”. Cells were then mixed to initiate mating. (B) At 8 hours post-mixing, cells
were fixed and scored using a hemocytometer to calculate mating efficiency. SMT3
and UBA2 conditional mutants cultured in cadmium-deficient conditions (–Cd) were
unable to form mating pairs and did not progress through conjugation. Cells from
+Cd cultures or –Cd cultures that were supplemented with cadmium two hours
prior to mixing (+Cd Addition) formed mating pairs. Solid white bars represent
wild-type (wt) cells, grey bars represent SMT3 conditional mutant (Smt3p) and
hatched bars represent UBA2 conditional mutant (Uba2p). Error bars (standard
error) are shown.
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Smt3p and Uba2p deficient strains are sensitive to DNA damaging agents
Generation of conditionally mutant strains further allowed us to examine
possible roles of this modification. Studies in budding yeast have shown increased
DNA damage sensitivity correlated with reduced SUMOylation (121–123). Multiple
studies in mammals show Smt3p modification of DNA repair proteins enhances the
repair response (75, 76). To test whether Tetrahymena relies on SUMOylationmediated DNA repair, we treated Smt3p and Uba2p conditional cell lines with the
DNA-damaging agents: methyl-methanesulfonate (MMS) that causes cell cycle arrest
and cisplatin that cross-links DNA causing cell cycle arrest and induces apoptosis in
yeast and mammalian cells (124–126). Wild-type, Smt3p conditional lines and
Uba2p conditional lines were cultured in the presence or absence of cadmium. Cells
were treated with either MMS or cisplatin, and then placed in drops with cadmium
(0.1 μg/mL) for 24 hours to evaluate cell survival. In the absence of cadmium, Smt3p
and Uba2p conditional mutants showed lower survival against MMS and cisplatin
compared with the same cells cultured with cadmium (Figure 9). This increased
survival after cadmium exposure occurs despite the negative effect of cadmium on
wild-type cell survival (Figure 9). This finding suggests that SUMOylation enhances
the DNA damage repair response in Tetrahymena as it does in other species. The
role of increased SUMOylation in conferring resilience to DNA damage in conditional
mutants is consistent with a role for SUMOylation during the programmed DNA
repair events of MAC development.
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Figure 9. Smt3p and Uba2p depleted cell lines are sensitive to DNA damaging agents.
SMT3 and UBA2 conditional mutants growing in the absence or presence of
cadmium (1 µg/mL) were treated with DNA damaging agents MMS (4.5 mM) and
cisplatin (2 mM). For each condition 216 single cells were isolated into drops with
medium supplemented with 0.1 µg/mL cadmium and incubated at 30 °C for 48
hours. Drops containing ≥500 cells were scored as viable and drop containing ≤10
cells were counted as unviable. Viability is expressed as percentage of viable drops
out of total number of drops. B2086 was used as the wild-type control. Error bars
(standard error) are shown.
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Discussion
Developmentally regulated SUMOylation during conjugation in Tetrahymena
Global increases in SUMOylation are known to result from exposure to
environmental conditions or specific reagents, for example hydroxyurea, heat shock
or ethanol (47, 59, 76). In contrast, few examples of large developmentally regulated
increases in SUMOylation have been reported. Our study reveals that the sexual
cycle of Tetrahymena is one such example. Immunoblot analysis of whole cell
extracts revealed differential modification of substrates by Smt3p between
vegetative and mating Tetrahymena cultures (Figure 4). Smt3p increased as
conjugation progressed with the highest Smt3p signal observed during MAC
differentiation stage. This increase is consistent with elevated SMT3 and UBA2
transcript levels in conjugating cells compared with vegetative or starved cells
(111). Our immunofluorescence studies also showed that Smt3p is predominantly a
nuclear protein during the MAC development stage (Figure 5). Together, the
immunoblot and immunofluorescence data suggest a requirement for protein
SUMOylation inside the developing MAC. During this period extensive genome
remodeling occurs including heterochromatin formation, transcriptional regulation,
DNA replication and DNA repair (96, 108), processes that have known connections
to SUMOylation in other species. In addition, our previous study of UBA2 and SUMO
genes in Paramecium revealed elevated transcript levels for both during
conjugation. RNAi generated knockdowns arrested conjugating cells and inhibited
programmed DNA elimination (111). While the nuclear events in Tetrahymena and
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Paramecium are dramatic, other reports of global changes in SUMOylation are
known. During mouse spermatogenesis two distinct expression profiles of SUMO
isoforms were detected, one during meiosis and the other in post-meiotic
spermatids suggesting an important role for SUMOylation in spermiogenesis (86). A
recent study in human keratinocyte differentiation also highlights SUMOylation as a
regulator of cell differentiation. In these cells, SUMO expression was upregulated by
calcium signaling at both the RNA and protein level, while degradation of SUMO
activating and conjugating enzymes resulted in abnormal differentiation of these
cells demonstrating key roles for SUMOylation in the keratinocyte differentiation
process (127).

The SUMO pathway is conserved in Tetrahymena
Despite the dramatic changes in SUMOylation in Tetrahymena we find that
most features of the pathway are conserved with other eukaryotes. As expected
based on other species, the localization of Smt3p and Uba2p is predominantly
nuclear (reviewed in (1)). In vegetative Tetrahymena cells both Smt3p and Uba2p
localized to the somatic MAC (Figure 3). Interestingly we did not observe a GFPUba2p or GFP-Smt3p signal in the mic nor did we detect the loss of mics in our
conditional cell lines. We examined more than 50 cells during various stages of
mitosis and could not detect a GFP-Smt3p signal from the micronucleus (data not
shown). We cannot claim that Smt3p is completely absent from the mic, but our data
support a much lower concentration in mics than in MACs during vegetative growth.
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As true for other eukaryotes, UBA2 and SMT3 are essential genes. We generated
germ-line deletions of SMT3 and UBA2 genes using homologous recombination. The
deletions were carried in the mics of heterokaryon cell lines that express wild-type
SMT3 and UBA2 from the somatic MAC. The progeny of these heterokaryon cells
have complete deletions of SMT3 or UBA2 and die following conjugation (Table 2).
This lethal phenotype is consistent with the deletion of SUMO and UBA2 genes in
yeast (32, 33) and mammalian model systems (81). Interestingly, our earlier work
with the ciliate Paramecium showed that RNAi knockdowns of SMT3 and UBA2 had
no effect on vegetative growth (111). In retrospect this lack of vegetative phenotype
is likely due to incomplete knockdowns providing a low level of SMT3 and UBA2
expression. As observed for other eukaryotes, Tetrahymena Smt3p and Uba2p
depleted cell lines were hypersensitive to DNA damaging agents. When we treated
Tetrahymena with MMS or cisplatin, cells depleted for Smt3p and Uba2p showed
increased sensitivity to both DNA-damaging agents (Figure 9). Several proteins
involved in DNA repair are SUMO substrates or proteins that interact with
components of the SUMO pathway (75, 76, 128). Examples include DNA repair
proteins such as PCNA (122), 53BP1 and MDC1 (75) and XRCC4 (128). 53BP1 and
MDC1 localize along with SUMO proteins to sites of double strand breaks that occur
as a result of DNA damage (75). XRCC4, an important protein in the mammalian
NHEJ pathway, depends upon transient SUMOylation for localization to the nucleus
(128). The NHEJ pathway is believed to be the key mechanism for repair of dsDNA
breaks generated during programmed DNA rearrangements that occur naturally
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during conjugation in ciliates (129). In Paramecium tetraurelia the RNAi induced
silencing of ligase IV (a partner of XRCC4 in NHEJ) during conjugation results in the
persistence of free broken ends during genome reorganization (130). The increasing
links between NHEJ pathway proteins and genome reorganization during ciliate
conjugation suggests potential targets for SUMOylation. The increased sensitivity of
conditional Smt3p mutants to DNA-damaging agents along with the accumulation of
Smt3p and Uba2p in the MAC anlagen is consistent with a role for SUMOylation
during MAC differentiation in ciliates.

SUMOylation pathway is required for cell pairing
When we reduced Uba2p expression levels in conditional mutant strains by
withdrawing cadmium, the cells were unable to form mating pairs. The same
conditional strains growing in the presence of cadmium proceeded through
conjugation normally as did wild-type cells. Although this result was unexpected,
there is precedence for SUMOylation dependent effects on mating. In the budding
yeast, SUMO-modification of transcription factor Ste12 is stimulated by mating
pheromone thus increasing its half-life and committing the cell to the mating
differentiation program (131). In addition, turnover of the yeast mating type factor,
α1 protein, is dependent on SUMO-targeted ubiquitin ligases SLX5 and SLX8 which
is consistent with the involvement of SUMO-mediated pathways (132). In our
system, the inability of Smt3p and Uba2p deficient Tetrahymena cells to form pairs
could result from altered gene transcription, modified signaling pathways or direct
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SUMOylation of the mating type protein. The experiments presented here do not
allow us to distinguish between direct and indirect SUMO-mediated effects but the
recent identification of the mating type protein from Tetrahymena provides an
opportunity to test some of these possibilities in the future (133). The dramatic
upregulation of SUMOylation in Tetrahymena coupled with the defined events of
genome alteration (heterochromatin formation, DNA elimination, DNA replication)
make this a rich system for analysis of SUMOylation function and dynamics.
Although the cell-pairing defect prevented the use of these lines to analyze defects
at later stages of conjugation, we expect strong phenotypes during macronuclear
development. Efforts are currently focused on developing alternative approaches
such as inducible RNAi knockdowns of SUMO pathway genes and identifying
SUMOylated proteins specific to conjugation for further analysis.
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CHAPTER 3 – PROTEOMIC STRATEGY TO IDENTIFY SMT3P SUBSTRATES IN
TETRAHYMENA

Early in the study of SUMOylation, most substrates were identified by chance
when immunoblot analyses revealed slower migrating bands that were unexpected.
Prior to 2004, the list of known Smt3p substrates had been compiled mostly by
chance discovery of SUMO modification on proteins of interest and direct candidate
analysis which most commonly involves epitope tagging of proteins purported to be
SUMO-modified and use of immunoblotting to confirm the SUMOylation state of
these proteins. Proteomic-based methods are increasingly useful in the
identification and validation of proteins modified by UBLs such as SUMO because
they offer high throughput and are far less labor-intensive than testing the
SUMOylation status of individual proteins. The most common approach involves
expression of tagged SUMO proteins followed either by single or double affinity
purification (reviewed in (92)). The use of immunoprecipitation (as one of the
affinity purification steps) is becoming very common because it utilizes specific
interactions between the antibody-coupled matrix and epitope-tagged SUMO
protein (134). Following the affinity purification steps, protein samples are resolved
by SDS-PAGE and then digested with a protease to yield short peptide fragments.
Peptides are further separated using by High Performance Liquid Chromatography
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(HPLC) and eluted peptides are injected into the mass spectrometer (MS)
instrument. Inside the instrument, the peptides are ionized and are directed to the
mass analyzer, which separates them on the basis of their mass-to-charge ratio
(m/z). The most commonly used method in the detection of UBLs is tandem MS
(also indicated as MS/MS) where primary intact peptides fragment into intense ions
that are selected for a second round of ionization, collision and detection. This
generates a series of peptidic fragments that have characteristic m/z values that are
used to construct the peptide sequence of the parent ion. In the ﬁnal stage MS data is
analyzed by matching the experimentally observed m/z values of each peptide with
the theoretical ones contained in a database. The in silico digest of the peptides is
done by peptide-search engines such as Mascot, Sequest and X!Tandem which will
look for shifts in the mass values due to addition of PTMs on protein substrates
(reviewed in (93)). There are issues with proteomics-based approach in the
identification of the SUMO proteome namely, low-stringency purifications, which
means fewer actual protein substrates than desired are immunopurified, and
ineffective protease inhibition which results in removal of the Smt3p moiety from
the protein substrates resulting in loss of the tag as well as general degradation of
proteins. As a result, methods that address these two primary concerns prove very
useful in the enrichment of SUMOylated substrates from a complex biological
mixture. Therefore, we used a denaturing cell lysis to prevent deSUMOylation of
substrates followed by two-step affinity chromatography coupled with HPLCMS/MS analysis for identification of SUMOylated substrates. Our data revealed

66

SUMO-modified proteins controlling chromatin structure, gene expression,
metabolism, and protein translation.
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Materials and Methods
Generation of Tetrahymena expressing His6-3FLAG epitope-tagged SMT3
The double epitope construct consisted of a hexahistidine (His6) tag followed
by a triple FLAG (3FLAG; FLAG tag sequence is DYDDDK) tag preceding SMT3 gene.
The tagged construct was inserted into the unique BsiWI and ApaI sites of
pBSYFP2_gtw plasmid (Douglas Chalker, Washington University, St Louis) under
the control of the MTT1 promoter along with a selectable marker in the form of a
mutant rpl29 gene that confers cycloheximide resistance via homologous
recombination. The tagged Smt3p construct was introduced into wild-type B2086
and CU428 strains as described (22). Cells successfully transformed with the His63FLAG-SMT3 construct were selected with cycloheximide (12.5 μg/mL). Individual
cells were isolated in drop medium to establish colonial cell lines that were
subsequently induced with 0.1 μg/mL CdCl2 and confirmed by Western Blot analysis
for expression of the His6-3FLAG-Smt3p construct. For control experiments, wildtype untagged strains were used.

Purification of Smt3p Conjugates
Tetrahymena strains containing His6-3FLAG-SMT3 were inoculated at 1000
cells/mL and grown in 500 mL of SPP medium to early log-phase (2×105 cells/mL)
at 30 °C in a platform shaker (110 rpm). Cells were harvested at room temperature
in 250 mL spin bottles (Corning, Corning, NY) by centrifugation at 2,250 rpm in a J2MC High-Performance centrifuge (Beckman Coulter, Indianapolis, IN). Cells were
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then washed once with 100 mL of Starvation Buffer (10 mM Tris-Cl, pH 7.5) and
then pelleted using the same conditions as the initial harvest. The pellet was
resuspended in 10 mL of lysis buffer (8 M Urea, 100 mM Na2HPO4-NaH2PO4, 10 mM
Tris-Cl, 5 mM imidazole, pH 8.0) containing 50 mM N-ethylmaleimide (NEM) and
protease inhibitors (final concentrations of 10 μg/mL chymostatin, 5 μg/mL
leupeptin, 12.5 μg/mL antipain, and 10 μg/mL E-64). The resulting whole cell
extract (WCE) was immediately placed on ice and further lysed by 15X pulses of
sonication (50% power, output setting 7) using a Misonix XL-2015 sonicator
(Qsonica, Newtown, CT). The WCE was clarified by centrifugation at 4 °C for 1 hour
at 25,000 rpm in a SW41 rotor (Beckman Coulter, Indianapolis, IN) and then further
clarified by passage through Miracloth (EMD Millipore, Billerica, MA) placed inside a
10 cc syringe. The filtered lysate (10 mL) was incubated with a 250 μL slurry of NiNTA resin (QIAgen, Valencia, CA) for 24 hours in a rotator at 4 °C. The resin was
washed for 10 minutes with 10 mL each of Wash Buffer A (8 M Urea, 100 mM
Na2HPO4-NaH2PO4, 10 mM Tris-Cl, pH 8.0), Wash Buffer B (8 M Urea, 100 mM
Na2HPO4-NaH2PO4, 10 mM Tris-Cl, 0.2% Triton X-100, pH 8.0) and Wash Buffer C (8
M Urea, 100 mM Na2HPO4-NaH2PO4, 10 mM Tris, 0.1% Triton X-100, pH 8.0). Wash
buffers were removed from columns by gravity flow (bottom stoppers opened).
Bound proteins were eluted 3X with 1.5 bed volumes of Wash Buffer A
supplemented with 250 mM imidazole resulting in a total volume of ~600 µL. The
elution fraction was then diluted to 10 mL with cold TBS (50 mM Tris, 150 mM NaCl,
pH 7.5). The diluted sample was then incubated with 100 µL of anti-DYDDDK
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agarose (GenScript, Piscataway, NJ) at 4 °C for 24 hours. Beads were then pelleted
by centrifuging at 1,000 rpm in a J2-MC High-Performance centrifuge (Beckman
Coulter, Indianapolis, IN) for 1 minute. Beads were transferred to 1.7 mL microfuge
tubes and then washed with 1 mL of TBS by rotating at 4 °C for 10 minutes. Wash
steps were repeated 3X times. Beads were pelleted after each wash by spinning at
1000×g in a mini centirfuge. TBS Proteins were eluted twice with 250 μL of alkaline
triethylamine (100 mM, pH 12.0). The control protein preparation for this
experiment was prepared in the exact same manner, except untagged wild-type
Tetrahymena strains were utilized.

Western Blotting and Coomassie Staining Analyses
To evaluate expression of the tagged SUMO lysates from the His6-3FLAGSmt3p and control wild-type strains were prepared for SDS-PAGE by addition of 4X
SDS loading buffer (63 mM Tris, pH 6.8, 2% glycerol, 2.3% SDS, and 0.05%
bromophenol blue) supplemented with 100 mM dithiothreitol (DTT) to a final
concentration of 1X. Protein samples were incubated for 5 min in a 95 °C heating
block before loading on 8% Bis-Tris acrylamide gels (27.5:1 bis-acrylamide ratio)
using Tris-Glycine SDS running buffer. SDS-PAGE gels were electrophoresed at 100
V for 2 hours. For Western Blotting, proteins were transferred to PVDF membrane
under wet conditions (Pall Corporation, Port Washington, NY) at 147 V for 1.5
hours. Western blot analysis was then performed with initial probing with antiFLAG primary antibodies (Sigma, St. Louis, MO) prepared as a 1:10,000 dilution in
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5% skim milk. Primary antibody incubation was performed overnight on a platform
shaker at 4 °C. Following this, membranes were probed with horseradish
peroxidase-conjugated secondary antibodies (Jackson Immunoresearch, West
Grove, PA), also prepared as a 1:10,000 dilution in 5% skim milk, for 1 hour at room
temperature. The membranes were incubated with Luminata Crescendo detection
reagent (EMD Millipore, Billerica, MA) for 2 minutes at room temperature. Results
were visualized with the ChemiDoc Imager (Bio-Rad, Hercules, CA) using the default
program for western blotting. Coomassie staining of Bis-Tris acrylamide gels was
performed by first fixing the gel in fixing solution (10% glacial acetic acid and 25%
isopropanol) for 3 hours and then staining with Coomassie R250 staining solution
(0.01% Coomassie R250 and 10% acetic acid) overnight at room temperature.
Destaining (10% glacial acetic acid) was done for 3-6 hours with gentle rocking.

In solution Trypsin Digestion and Protein Fractionation
Eluates from the second round of purification using FLAG resin were pooled
together and digested with trypsin (1:100 enzyme:protein ratio; Piercenet,
Rockford, IL) at 37 °C for 24 hours. The tryptic digestion was quenched by addition
of 0.1% trifluoroacetic acid (TFA). Peptide preparations were individually loaded
onto C18 resin (Thermo Scientific, Waltham, MA) and separated using a 35-min
gradient from 2.5 to 97.4% acetonitrile.
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Mass Spectrometry Acquisition and Database Search
Eluted peptides were then directly entered into an ESI QuadTOF mass
spectrometer (TripleTOF 5600; AB Sciex, Concord, Canada). The instrument was
coupled with an Eksigent Nano LC-2DPlus with nanoFlex cHiPLC electrospray
ionization (ESI) system (Eksigent, Dublin, CA). The sample acquisitions were
performed using a “trap and elute” configuration on the nanoFlex system. The trap
column (200 m 0.5 mm) and the analytical column (75 m 15 cm) were packed with
3 m ChromXP C18 medium. Samples were loaded at a flow rate of 2 nL/min for 10
minutes and eluted from the analytical column at a flow rate of 300 nL/min in a
linear gradient of 5% solvent B (95% acetonitrile, 0.1% formic acid, v/v) to 35%
solvent B in 90 min. The column was regenerated by washing with 80% solvent B
for 10 minutes and re-equilibrated with 5% solvent B for 10 minutes. For standard
data-dependent analysis experiments, the mass spectrometer alternated between
acquiring a full 250-ms scan (TOF-MS) and subsequent MS/MS spectra of the 50
most abundant precursor ions with a 50-ms scan. The selection criteria for parent
ions included intensity, where ions had to be greater than 100 counts/s with a
charge state between +2 to +4 and were not present on the dynamic exclusion list.
Once an ion had been fragmented by MS/MS, its mass and isotopes were excluded
for a period of 6 s. Ions were isolated using a quadrupole resolution of 0.7 Da and
fragmented in the collision cell using collision energy ramped from 15 to 45 eV
within the 50-ms accumulation time. In the instances where there were less than 20
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parent ions that met the selection criteria, those ions that did were subjected to
longer accumulation times to maintain a constant total cycle time.
Data were analyzed using the Tetrahymena Genome Database (TGD)
<http://ciliate.org/> in conjunction with the Mascot v2.5 search algorithm (Matrix
Science, Boston, MA). MS searches allowed for a search tolerance of 10 ppm for the
peptide mass tolerance and 0.2 Da for the MS/MS tolerance. The enzyme selected
for protease digestion was trypsin with 2 missed cleavages specified. The charge of
the peptides to search was set to +2, +3 and +4. Initial peptide filtering was done at
an FDR of 1% and proteins were required to have 2 or more peptides identified at
the 1% FDR level. The MS spectra were searched against a reverse database to
estimate the false discovery rate. Figures and tables of the identified proteins were
made using information from both the TGD and UniProt
<http://www.uniprot.org/>. Finally, the sequences of identified proteins were
analyzed to locate potential SUMOylation consensus motifs using SUMOsp2.0
<http://sumosp.biocuckoo.org/>.

73

Results
Affinity Purification of Smt3p Conjugates from Tetrahymena
The main challenge in identifying Smt3p substrates is the low abundance of
protein substrates relative to the total protein in the cell. In addition, SUMOylation is
often a short-lived and transient modification which means that few proteins in the
cells are likely to be SUMOylated. The use of two rounds of purification serve to
enrich for SUMOylated substrates for identification in the mass spectrometer. To
determine the catalog of SUMO proteins (the SUMOome) in vegetative cells, we used
a two-step affinity purification followed by HPLC-coupled MS protein identification.
The dual tag construct consisted of the N terminal 6His tag followed by a 3FLAG tag.
We used the MTT1 promoter for cadmium-based induction of the tagged Smt3p
(Figure 10A). The construct was transfected in Tetrahymena strains at the rpl29
locus that confers resistance against the drug cycloheximide. It should be noted that
these cells also express wild-type Smt3p from the endogenous locus. As shown in
Figure 10C expression of the tagged Smt3p was cadmium dependent. A low
concentration of cadmium (0.1 μg/mL CdCl2) was used to induce the expression of
the dual-tagged 6His-3FLAG-Smt3p protein, to avoid inundating the cell with excess
Smt3p protein. The tagged Smt3p was detected in its non-conjugated (free) form at
approximately 14 kDa but the majority of signal was located in higher mass regions
of the gel as expected for SUMO conjugated to target proteins.
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Figure 10. The psYFP2_His6-3FLAG-SUMO vector and its expression product. (A) A
map of the plasmid encoding His6-3FLAG-Smt3p construct that was used to
transfect wild-type Tetrahymena strains. (B) Schematic representation of the dual
epitope tag containing the N-terminal His6 epitope tag and the second 3FLAG
epitope tag. Target proteins are conjugated at the C-terminus of Smt3p. For
immunoblotting analyses, antibodies directed against the 3FLAG epitope tag were
used. (C) Immunoblotting of the whole cell extract (WCE) prepared from His63FLAG-Smt3p expressing strain and wild-type untagged strain. Expression of His63FLAG-Smt3p is driven by the MTTp promoter. Growth medium was supplemented
with 0.1 μg/mL CdCl2 to induce the expression of the tagged form of Smt3p. Free
Smt3p is indicated with an arrow head at ~14 kDa. The high molecular weight
region containing numerous proteins that are likely to be Smt3p substrates is also
indicated with a bracket. Low amounts of cadmium were used to minimize
overexpression which contributes to non-typical conjugation of protein substrates
by Smt3p.

In the first round of affinity purification, the His6 tagged was bound to NiNTA agarose under strongly denaturing conditions (containing 8 M urea) in order to
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solubilize the majority of cellular proteins by denaturation as well as to ensure that
proteins identified in the proteomic screen are directly conjugated to Smt3p. The
lysis buffer also contained NEM and protease inhibitors to inhibit the activity of
SUMO proteases from removing Smt3p from substrates. A single round of
purification is not recommended when purifying UBL substrates as it has been
shown to result in a large number of false positives (109). This is especially the case
with Ni-NTA purification as many proteins bind non-specifically to this resin in
yeast (45, 109, 135). In order increase the purity of the sample, a second
purification step was performed with anti-FLAG resin. Following incubation with
anti-FLAG resin, proteins were eluted under highly alkaline conditions (100 mM
alkaline triethylamine).
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Figure 11. Overview of the double affinity purification and identification of His63FLAG-Smt3p tagged proteins. (A) The two-step affinity purification workflow is
described in more detail in the Materials and Methods section of this chapter. The
actual procedure of the double-affinity purification includes additional steps such as
culturing and lysis of the cells, denaturation and renaturation of the proteins, and in
solution digestion with trypsin and database searches. (B) Fractions from Ni-NTA
purification were collected after each step during purification as the crude cell
extract (CR), flow through (FL), elution (E), and beads (B). Samples were loaded
proportionally and resolved by SDS-PAGE (10% gel). Fractions from untagged wildtype strain are on the left half (lanes 1-4) while proteins from the tagged Smt3p
strain are on the right (lanes 5-8). Smt3p conjugates and free Smt3p protein are
indicated.

Identification of SUMOylated Substrates by LC-MS/MS
Eluted samples from the two-step purification were digested in solution with
trypsin. The resulting peptides were extracted and loaded onto a reverse-phase
column and eluted with increasing concentrations of acetonitrile (ACN) directly into
the mass spectrometer. We chose a QuadTOF mass spectrometer to identify the
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protein substrates because this instrument has high sensitivity and accuracy. The
mass spectrometer was configured to acquire both accurate mass (MS) and
sequence (MS/MS) information for the eluting peptides. We used Mascot algorithm
to identify the peptides against a conceptual translation of Tetrahymena gene
sequences from Tetrahymena Genome Database (TGD) and Uniprot. Proteins that
were included in our list of SUMO substrates had to meet two criteria: 1) they must
be unique to the Smt3p immunoaffinity purification (not in the untagged cell
purification) and 2) they must be identified by 2 or more peptides (Table 3 and
Table 7). Proteins that were identified in the control wild-type untagged sample
were eliminated from the tagged Smt3p substrate dataset even if they met the
criteria stated above for MS search. Proteins in the untagged cell sample could be
highly abundant proteins that were carried over during the two purifications. As
predicted from the above-mentioned immunoblot, little overlap was observed
between the datasets of the tagged Smt3p and untagged purifications.
Analysis and Categorization of SUMOylated Substrates
A total of 153 proteins were identified from five independent runs in the
His6-3FLAG-Smt3p purification (full list available in Appendix Table 7). We
identified numerous novel proteins as Smt3p substrates as well as others that have
been previously identified (Table 3). Many of these proteins are orthologous to well
characterized SUMO substrates found in other organisms. For example,
Heterochromatin Protein 1 (HP1) is a SUMO substrate (136, 137) and the ribosomal
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protein Rps17 has been purified from a SUMO proteomic screen in Drosophila (48)
(Table 3).

Table 3. List of selected Smt3p substrates identified in vegetative Tetrahymena.
Identified Proteins

Molecular
Mass (kDa)

TGD ID

SUMOylation Machinery
Smt3p*
10.2
TTHERM_00410130
Ubc9p*
24.0
TTHERM_00522720
Metabolic Enzymes
Gpm1*
31.6
TTHERM_00641240
Cit1*
63.6
TTHERM_00529790
Pgi1*
63.6
TTHERM_01108700
Tcb2
24.7
TTHERM_00068170
Ribosomal Proteins
Rpl20
29.2
TTHERM_00476670
Rpl43
11.4
TTHERM_00075670
Rps11
18.1
TTHERM_01109770
Rps17*
14.9
TTHERM_00762890
Rack1*
38.5
TTHERM_01113100
Chromatin-Associated
HTA3*
15.3
TTHERM_00143660
TGP1*
83.4
TTHERM_00499420
HP1*
44.2
TTHERM_00245410
Cytoskeleton Structure
DFB1
48.1
TTHERM_00128280
TTNA
98.9
TTHERM_00006320
MYO2
210.9
TTHERM_01035740
Other
ATP2
53.4
TTHERM_00585260
Hsp60*
61.6
TTHERM_00196370
PRE10*
27.6
TTHERM_00487110
Liver F-Antigen
46.0
TTHERM_00678260
*Previously identified as SUMO substrates in other species.

References
(138, 139)
(140)
(141, 142)
(143)
(45)

(48)
(144)
(145)
(146)
(136, 137)

(147)
(109)

We compared our tagged Smt3p dataset with separate studies in S. cerevisiae
(45), D. melanogaster (48) and A. thaliana (148) that utilized a similar two-step
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affinity purification (Figure 12). There was only one protein in common with the
Arabidopsis study and this is likely due to the fact that affinity purification in that
study yielded only 20 proteins. A total of 11 proteins were common between
Tetrahymena and Drosophila and 16 proteins were common in the purifications
from Tetrahymena and yeast. There are 3 proteins that are common all three
purifications. The presence of Tetrahymena proteins in purifications from
Drosophila and yeast adds confidence to these proteins as authentic Smt3p
substrates.

Figure 12. Comparison of SUMO substrates identified using 2-step purification in
various model systems. Tagged Smt3p dataset from two-step purification in
Tetrahymena were compared to the same from purifications from Drosophila and S.
cerevisiae. Three proteins are common between all three organisms making them
highly likely to be true Smt3p substrates.

In a separate study, tagged Smt3p conjugates were isolated under native
conditions using the same two-step affinity purification scheme, and 141 protein
substrates were identified (Qianyi Yang and James Forney unpublished). There is
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some overlap between this dataset and the one described above where Smt3p
conjugates were isolated under denaturing conditions (Figure 12). These protein
substrates that were purified from both lysis conditions are considered high
confidence Smt3p targets (Table 8).

Figure 13. Overlap between Smt3p substrates purified under denaturing and native
conditions. All proteins reported to be SUMOylated in our proteomic screen using
denaturing conditions were manually extracted and compared to those found by MS
using native conditions. Proteins considered in the denaturing lysis purification
analysis are included in the Table 7 and proteins common to both lysis conditions
are presented in Table 8. 20 proteins are purified from both lysis conditions
indicating that these proteins are high confidence protein substrates of Smt3p.

In an attempt to gain insights into the functions of potential Smt3p substrates
identified in our proteomic screen for vegetative Tetrahymena, we used the
Tetrahymena Genome Database (TGD) and the Uniprot Knowledgebase to categorize
these proteins based on their subcellular localization (Figure 14A) and biological
functions (Figure 14B).
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Figure 14. Graphical representation of both the cellular location and biological
function of Smt3p candidate substrates. (A) We used the Tetrahymena Genome
Database (TGD) and the Uniprot Knowledgebase to categorize the identified
substrates based on cellular location. As expected, many of these proteins are
nuclear proteins. However, a surprisingly high number of these proteins that are
present in the cytosol and/or localized to other non-nuclear organelles. (B) These
same database sources were also utilized to graphically represent the diverse
functional categories (Gene Ontology terms) to which these identified SUMOylated
substrates belong. The largest such category was found to be comprised of proteins
involved in metabolism which suggests that SUMOylation is not highly centralized in
the nucleus. However, SUMOylation clearly plays a role in other biological
phenomena, including DNA-related processes, protein translation and folding,
crosstalk with other PTMs etc. As in the case of Figure 14A, there are many proteins
with unknown function and as more information is made available in the TGD, the
fraction of proteins categorized as such is likely to decrease.
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From this analysis, a few conclusions can be made. Firstly, as expected the
largest localization category is the nucleus (25% of proteins identified in our study
are predicted to reside in the nucleus). Both yeast and fruit fly have a higher
percentage of nuclear substrates, 43% and 33% respectively. Second, we also
observed a large percentage of proteins that are predicted to be cytosolic, or
associated with other organelles which would suggest that SUMOylation is a less
nuclear centralized process than previously thought. For example, 22% of the
proteins were localized in soluble fractions while 13% and 9% are found in the
ribosome and mitochondrion respectively. It is plausible that some of the identified
non-nuclear proteins may translocate to the nucleus upon modification by Smt3p. A
third conclusion is that protein substrates of SUMOylation belong to broad and
diverse range of biological processes which is expected for this important PTM. In
addition to DNA-related processes (15% in Tetrahymena), a substantial number of
proteins in other cellular processes were also identified as targets of SUMOylation.
For example, numerous proteins in Tetrahymena are involved in various metabolic
pathways (23%) and the same is the case in Drosophila (28%). We also observed
several proteins (14% in Tetrahymena) that play a role in protein translation (as
part of the larger ribosome complex) similar to both yeast and Drosophila. Other
processes include crosstalk with PTMs (9%), response to cellular environment (3%)
and structural maintenance (3%). Interestingly, components of the SUMO pathway
such as the E2 conjugating enzyme Ubc9p and Smt3p protein itself were observed in
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our proteomic screen consistent with similar observations in other systems (Table
3) (149–151).
For novel candidate SUMOylated substrates, we searched the amino acid
sequences using SUMOsp2.0 (152) for matches to a SUMO target consensus
sequence (ψKXE) present in many SUMOylated proteins (reviewed in (2)) (Table 4).
While SUMO conjugation of substrates does not always occur at SUMO consensus
motifs in previously identified cases (reviewed in (42)), presence of these motifs
suggests strong candidate lysines in the substrates that might be modified and,
hence, a starting point for subsequent site-directed mutagenesis studies aimed at
identifying the biological effect of SUMOylation in desired target proteins.

Table 4. Consensus Smt3p target sites.
Identified Proteins
Heterochromatin protein 1
CHROMOdomain protein 2
C2H2 (zinc-finger protein)
Ubiquitin-60S
Phosphoglycerate mutase 1,
GPM1
HSP70
HSP60
SSA5 (DnaK protein)
CIT1
ATP synthase
RACK1
Sd2e domain protein
Ubc9p
DFB1
TTNA

Smt3p Consensus Site
(ψKXD/E)
VKWE, VKQD, VKQE
VKRE
PKIE, IKKE
VKHD
KKQE
FKVE, LKDE
LKGE
FKVE, MKDE
LKHE
MKVE, LKFE
FKVE
IKQE, LKQE, LKHE
LKQE, LKDE
VKNE, LKSE, LKDE, LKTE, IKNE,
LKEE
LKEE
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Sequence analysis also revealed that our SUMOome contains a comparable
number of ψKXE SUMO modification consensus motifs per protein to that contained
in previously reported SUMOylation targets from other species (Table 5). The wildtype internal rejects (untagged strain) list contains almost three-fold fewer SUMO
consensus sites per protein than the His6-3FLAG-Smt3p proteome (0.6 versus 2.2)
and is similar to the fraction in the total Tetrahymena proteome (0.6 versus 0.8)
(Table 5).

Table 5. Frequency of Smt3p consensus sites in known SUMO target proteins
compared with this study. Smt3p modification consensus sites of the form ψKXE
were identified using SUMOsp2.0 (152) set to high threshold.
Data Set

Number
of
proteins
265
60
16,102
37

Published Smt3p substrates
His6-3FLAG-Smt3p proteomea
Tetrahymena proteome
Wild-type internal rejectsb
aProteins identified in this study
bProteins purified from the untagged strain

Predicted
consensus
sites
517
132
12,771
21

Proteins
without
consensus
49
64
9,440
9

Sites
per
protein
2.0
2.2
0.8
0.6
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Discussion
Our proteomic screen employed double-affinity purification coupled to mass
spectrometry (MS) to identify protein substrates. This approach generates
improved purity and lower background than single affinity purifications. In
experiments where Smt3p substrates were purified utilizing a single round of
purification (45, 109, 135), many of the identified proteins were also purified from a
mock untagged strain which would suggest that a single round of purification do not
produce a pure sample for use in MS. Using a double-affinity purification scheme is
then more suited for identifying Smt3p substrates as it yields cleaner sample and
control preparations.
A second important feature of our approach that adds confidence to our
SUMOome dataset is the use of a QuadTOF mass spectrometer for the collection of
the MS/MS spectra. The advantage of this particular instrument is its high
sensitivity (femtomoles). This is critical because only a small fraction of total
proteins in the cell are SUMOylated at any given time. The high sensitivity of the LTQ
mass spectrophotometer is helpful then, to identify the low amounts of SUMOmodified peptides.
We concede that even with our careful controls, there are likely to be some
Tetrahymena proteins that may be falsely identified as Smt3p substrates. An
example of this would be the heat shock proteins that we identified in only one
experiment; these proteins may have been purified because of stress suffered by
cells immediately prior to lysis. Other examples could be some of the ribosomal
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proteins as well as proteins involved in heavy-metal metabolism which may have
been identified in our proteomic screen because we used cadmium-driven MTT1
promoter for expressing the tagged Smt3p. Despite using denaturing conditions (8
M urea) for lysis of cells, it is possible that some of the proteins identified in our
proteomic screen are carried through the double-affinity purification because they
form highly stable complexes with protein substrates that are attached to Smt3p.
These concerns can be addressed by immunoblotting studies with antibodies
against protein substrates to confirm the SUMOylation state of these proteins
and/or by identifying lysine sites of Smt3p attachment (See Future Directions).
The more obvious targets of Smt3p in our proteomic screen are nuclear
proteins that are involved in gene expression. Many of these protein substrates play
a role in chromatin remodeling, transcription and mRNA processing (Table 3). This
is consistent with a role of SUMOylation as a predominantly nuclear process
(reviewed in (2)).
Our proteomic screen did not provide full coverage of the entire SUMOome.
This is evident by the fact that we did not identify proteins such as topoisomerase II
(4) and RanGAP1 (153) which are well known Smt3p substrates in yeast.
Optimization of the double-affinity procedure to minimize high abundant sticky
proteins may help in getting a purer sample. A possible solution is to separate the
nuclei from the cell using differential centrifugation and analyze the nuclear extract
using mass spectrometry. Lastly, it is possible that these well-known Smt3p
substrates are low abundance proteins in Tetrahymena making it difficult to carry
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these proteins over two purification steps. While our proteomics screen did not
cover the entire SUMOome, we were able to identify several novel protein
substrates of SUMOylation in Tetrahymena such as the ER protein, TCB2 and the
deep-fiber bundle protein, DFB2. Similar studies have been performed in mammals,
Drosophila and yeast using similar proteomic approaches (45, 46, 48) where full
coverage of the SUMOome was not achieved. It may require multiple runs as well
other proteomic approaches to produce a more comprehensive list of Smt3p targets.

SUMOylation in DNA-related Processes
Many protein substrates of SUMO are nuclear proteins with important roles
in the regulation of transcription, maintenance of chromosome and chromatin
structure and DNA repair (reviewed in (154, 155)). The effect of SUMOylation on
transcription factor activity generally leads to repression as opposed to Ubmodification which tends to result in transcriptional activation (reviewed in (154)).
As observed in proteomics studies in yeast (45) and mammals (156), the largest
group of proteins identified in SUMO proteomic screens were involved in DNArelated biochemical processes. The same trend was observed in our proteomic
screen. Chromatin proteins such as the histone H2A variant (HTA3) were identified
as Smt3p substrates. Another nuclear protein (TTHERM_00245410) that contains a
CHRromatin Organisation MOdifier (CHROMO) domain was also captured five times
in our proteomics screen. This is a homolog of a heterochromatin protein
(HP1/CBX1) in mammals that recognizes and binds histone H3 tails that are
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methylated at Lys-9 (H3K9) leading to a heterochromatic state through epigenetic
repression (136). It is known to interact with SUMO-1 in affinity-capture
experiments (137). One proposed model is that SUMOylation of CBX1 causes the
protein to localize to the nucleus. Mutants that cannot be SUMOylated are unable to
localize in nuclear domains and are instead found dispersed throughout the cell
(136).
As many of the SUMOylated proteins identified to date are transcription
factors, coactivators, or corepressors that associate with DNA (reviewed in (89, 91,
154)), it is not surprising that our affinity purification captured several nuclear
protein substrates highlighting the importance of this PTM in DNA-related
processes. Transcriptional factors and other chromatin-associated proteins such as
histones have been demonstrated to be modified by other PTMs such as
phosphorylation, acetylation, methylation, and ubiquitylation (reviewed in (154)).
As a result, analysis of SUMOylation-dependent changes in chromatin dynamics is
undoubtedly made complicated by the fact that many of the enzymes that regulate
chromatin structure are themselves modified by several PTMs. Identification of
proteins involved in DNA-associated processes as Smt3p substrates aids in
understanding the crosstalk between different PTMs.
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SUMOylation directs Ribosome Maturation
The control of ribosome biogenesis is a critical process which ensures that
protein synthesis is coordinated with cell growth and proliferation. Several
proteomic studies aimed at identifying SUMO substrates have shown that ribosomal
proteins and trans-acting factors have been identified as potential Smt3p substrates
in various model systems (45, 48, 109, 157). We too, identified numerous ribosomal
subunit proteins that are part of the greater ribosomal complex in our proteomic
screen - RpS4, RpL15, RpL23, RpL4, RpL18, RpL22, RpL40, and RpL36 were all
purified as Smt3p substrates. The presence of several ribosomal subunits would
suggest that the multi-protein ribosomal complex often contains multiple
SUMOylated proteins (Table 3 and Table 7) some of which possess several predicted
sites of Smt3p attachment (Table 4). It is not entirely clear why so many ribosomal
proteins are substrates of SUMOylation. Smt3p could be part of a nuclear
surveillance system that ensures proper protein translation. Indeed, under
conditions of stress that require increased protein translation for stress response,
an overall increase in SUMOylation is observed which may help in ribosomal
maturation, assembly and function (47, 76). This role of SUMOylation is supported
by mutation studies where inhibition of SUMOylation affects ribosome export (157).
The ribosomal protein RpL40, involved in regulation of protein translation, was also
identified as a substrate of Smt3p. RpL40 has two components - ubiquitin and
ribosomal 60S subunit. The Ub component of RpL40 is believed to facilitate the
assembly of the ribosomal protein into ribosomes upon export to the nucleus (158).
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In a recent study, investigators used a specific protease inhibitor as a way of
inhibiting the activity of SENPs proteases in prostate cancer cells stably expressing
SUMO (159). A combination of stable isotope labeling with amino acids (SILAC)
quantitative proteomic technique was used to identify more than 900 putative
target proteins of SUMO, one of which was RpL40 (159). Regulation of RpL40 by
Smt3p modification may shed light on the mechanism underlying prostate cancer
progression.
As demonstrated in Table 3, our work provides a few examples of clustering
of SUMOylation in the ribosomal complex. The high degree of incidence of this
phenomenon in our data strongly indicates that substrate clustering may be an
important mechanism by which SUMOylation regulates large protein complexes. An
alternate model of Smt3p regulation may be that it regulates cellular processes by
targeting macromolecular complexes rather than individual proteins as typical of
other posttranslational modifications. Such coordinated SUMOylation could function
to localize an entire protein complex to a specific subcellular location or stabilize the
protein complex by inhibiting modification by Ub. Clearly, additional work aimed at
elucidating the functional strategy underlying this mechanism will provide
important insight into how SUMOylation regulates these larger macromolecular
complexes.
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SUMO in Metabolic Homeostasis
The first identified targets for SUMO modification were mostly nuclear
proteins (reviewed in (82)). However, more recent studies have identified a number
of cytoplasmic Smt3p targets (reviewed in (160, 161)). Extra-nuclear roles of
SUMOylation have been described in regulation of G protein signaling,
phosphorylation crosstalk, mitochondrial fission/fusion, glucose transport as well
as regulation of neuronal integrity and synaptic function (41, 162, 163). In some
cases SUMOylation regulates master proteins to affect entire metabolic pathways
(reviewed in (160)). Phosphoglycerate mutase 1 (GPM1) (Table 3), which
participates in the glycolysis cycle, was identified as an interacting partner of Smt3p
through a bimolecular fluorescence complementation assay in yeast (141). The
same protein, GPM1, was also identified as a SUMO substrate in a separate
proteomics screen in yeast (164). In Drosophila, a genome-wide screen to
systematically search for modulators of citrate synthase (CS) identified Smt3p as an
active regulator of the CS enzyme (143). Flies that are SMT3 heterozygous mutants
have increased CS activity, providing additional support for SUMOylation in
regulating mitochondrial function. Considering that SUMOylation greatly influences
protein activity, stability and protein interactions, it is not surprising that
SUMOylation regulates the function of metabolic enzymes within pathways.
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FUTURE DIRECTIONS
RNAi based knockdown of SUMOylation pathway genes
The role of SUMOylation in regulating diverse critical processes in the
eukaryotic cells is well documented (reviewed in (2, 82, 91)). We observed that
there is an increase in the levels of Smt3p during Tetrahymena thermophila
conjugation (Figure 4). Conditional mutants of Smt3p and Uba2p, in which Smt3p
and Uba2p was depleted, were unable to form mating pairs and therefore could not
progress through conjugation. This non-pairing phenotype prevented us from
analyzing the requirement of SUMOylation during conjugation. To circumvent this
issue, we can use an RNAi-based approach to knockdown the levels of SUMOylation
pathway genes. Previous studies in another ciliate Paramecium tetraurelia
demonstrated that RNAi-based silencing of Smt3p and Uba2p inhibited the excision
of IES elements during the macronuclear development stage of conjugation in this
organism (111). We anticipate that RNAi-mediated downregulation of SUMOylation
pathway genes in Tetrahymena will lead to a similar phenotype with cells arresting
during MAC development stage.
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Identification of SUMOylation sites on protein substrates
An alternate approach to study the requirement of SUMOylation during
conjugation (or vegetative life cycle for that matter) is to identify and alter
SUMOylated substrates. We intend to employ a MS-based approach to identify the
catalogue of proteins that are modified differentially by Smt3p in response to the
sexual life cycle and the various stages therein. Proteomics approaches which aid in
identification of sites of SUMOylation are especially helpful in this case as they yield
useful information for mutational analyses where sites for Smt3p attachment can be
inactivated in protein substrates. To this end, we have generated a Tetrahymena
strain expressing Smt3p V85K that can be used in conjunction with mass
spectrometry to map SUMOylation sites on purified proteins. It is technically
challenging to identify sites of SUMO attachment to protein substrates because
common proteases such as trypsin generate long SUMO peptides attached to target
lysines that add to the mass of the peptide and are subject to fragmentation during
MS/MS. The resulting fragmentation patterns in the mass spectrum are very
complex and cannot be easily interpreted by conventional MS algorithms. The
Smt3p mutant with V85K mutation leaves a GG remnant on target lysine residues on
substrates when affinity-purified substrates are subjected to protease digestion
with Lys-C. In this case, the MS instrument can be configured to detect the specific
mass shift because of attachment of the diglycine remnant to proteins substrates
(46). Preliminary data shows that we have identified SUMOylated lysine residues on
several proteins from both vegetative and mated Tetrahymena Smt3p V85K strains.
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For protein substrates of Smt3p identified earlier that are not purified using the
V85K mutant, we will have to use in vitro and/or in vivo methods to confirm their
SUMOylation status.

HP1 and HTA3 as potential Smt3p substrates
A CHROMO domain-containing protein related to Heterochromatin Protein 1
(TTHERM_00245410, here referred to as HPR) was identified in our two-step
purification procedure in Tetrahymena (Chapter 3). HP1 was also identified as a
SUMO target in yeast. The hinge domain of murine HP1 has been demonstrated to
be modified by SUMO (136). In this particular study, the authors observed that de
novo SUMOylation of HP1 targets the protein to pericentric heterochromatin.
Microarray expression profile shows that the levels of HP1 in Tetrahymena are
upregulated during conjugation with the peak during MAC development (~3-fold
higher than vegetative growth). We know that major regions of the genome in the
developing macronucleus for heterochromatin before their elimination. My model
for the role of HP1 in MAC development involves de novo targeting HPR to these
heterochromatic regions followed by methylation of histone H3 lysine 9 and lysine
27 to stabilize the heterochromatin and allow CHROMO domains to bind the
methylated lysines. Subsequent events include the formation of sub-nuclear
structures that contain protein machinery required for DNA rearrangement.
This model makes a clear prediction that HPR should localize to
heterochromatin DNA regions prior to histone H3K9 methylation. To test this, we
can use SMT3 and UBC9 (generated by Qianyi Yang) conditional strains and
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transfect them with GFP-HP1. Accumulation of HPR to heterochromatic regions in
SMT3- and UBC9-depleted cells would suggest SUMO does not target HPR to
heterochromatic regions of the developing MAC. A second method to test the same
would be to make use of Lys mutants of GFP-HP1 that are unable to be SUMOylated
expressed in wild-type Tetrahymena. If HPR is immunopurified using the V85K
mutant, the exact site of Smt3p attachment on HP1 may be determined using the
approach described above (see section on Identification of SUMOylation sites on
protein substrates). Lys mutants of HPR would also help in identifying the site of
Smt3p attachment. Western blot analysis would confirm the formation of SUMOmodified species of HP1 (versus un-modified) if the target Lys is present in HP1. The
slow-migrating band corresponding to the Smt3p-HPR would be absent in HP1 Lys
mutants. Chromatin Immunoprecipitation (ChIP) assay will confirm whether SUMOHPR is physically associated with heterochromatic regions versus unmodified HPR1.
SUMOylation of HPR may also modulate interactions with other proteins and could
include other CHROMO domain-containing proteins such as Pdd1p and Pdd3p, both
required for DNA elimination in Tetrahymena (96, 97).
Another SUMO target of particular interest is the histone H2A variant, HTA3
that was identified as a substrate of SUMO in Tetrahymena, yeast and fruit fly. In
yeast, SUMOylation H2A.Z (HTA3 in Tetrahymena, TTHERM_00143660) serves as a
specific chromatin mark for chromosome relocation to nuclear periphery for DSB
repair (145, 165). Excision of IES elements in Tetrahymena, begins with induction of
DSBs that eliminate mic-limited sequences followed by re-ligation of adjacent MAC-
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destined DNA. These events occur within DNA rearrangement foci in the developing
macronucleus. Our model is that SUMO modification of HTA3 is required for its
localization to DSBs in DNA rearrangement foci. Utilizing specific IES elements such
as the M- or R-element is useful here as the excision of these IESs is well studied.
GFP-tagged HTA3 along with the use of anti-Smt3p antibody can be used in
immunofluorescence experiments to determine whether the two proteins colocalize in the anlagen during MAC development. In addition to aiding DSB
relocation, SUMOylation of HTA3 may be responsible for recruiting proteins
involved in DSB repair by causing conformational changes that promote assembly of
downstream repair factors. Homologous sequences are absent at DSB break sites
and the cell switches to a type of Non-Homologous End Joining (NHEJ) repair
mechanism as has been described in Paramecium (130). It is possible that the same
process is in effect in Tetrahymena in the ligation of MAC-destined DNA following
resection of IES elements. ChIP assays utilizing epitope-tagged versions of HTA3 can
be used to identify interactions with other proteins and establish whether HTA3 is
associated with eliminated heterochromatic on retained MAC-destined DNA regions.
This will be especially helpful as Ku proteins and XRCC4 of the NHEJ pathways are
known SUMO substrates and SUMOylation has well-defined roles in DNA repair
(128). Conditional mutants of the SUMOylation pathway can be used to test for
decreased SUMOylation status of HTA3. The SUMOylation-deficient strain (∆GG) can
also be used to check reduction of histone SUMOylation. And RNAi-based approach
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to reduce SUMOylation pathway protein levels can be effectively used to test
whether cells accumulate DSBs in the anlagen as conjugation progresses.

In vitro validation of Smt3p Conjugates found through Global MS Analysis
The zinc-finger C2H2 protein and Glycine Cleavage System protein
(TTHERM_00499390, here referred to as HPM1) are among the Smt3p proteins
identified in our two-step purification procedure in Tetrahymena (Chapter 3) that
were also identified in yeast or fruit fly. These proteins are of special interest
because microarray expression data shows that transcript levels are upregulated for
these proteins during conjugation, specifically during MAC development. This would
suggest that these proteins are involved in the nuclear events of MAC development.
We can validate these protein substrates as Smt3p conjugation targets using
a bacterial SUMOylation assay. For this in vitro assay, we will generate E. coli
expressed enzymes of the SUMOylation pathway from Tetrahymena thermophila
(Smt3p, Aos1p/Uba2p, and Ubc9p) as well as epitope-tagged candidate Smt3p
substrate. Single lysine mutants of Smt3p protein substrates will be used to confirm
the exact site of Smt3p attachment. The detection of Smt3p conjugates in this system
is facilitated by the lack of an absolute requirement for E3-type ligases in
SUMOylation as well as by the absence of Smt3p proteases that deconjugate Smt3p
from the substrate (reviewed in (2)). While bacterial SUMOylation systems may not
completely recapitulate the specificity of SUMOylation reaction in vivo, they have
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been repeatedly validated as a useful approach for confirming SUMOylation targets
(48, 166).

In vivo validation of Smt3p Conjugates found through Global MS Analysis
To clearly demonstrate that a particular protein (e.g. HPM1, HTA3) is a target
of Smt3p, an in vivo approach is most helpful in addition to the in vitro method
described above. Most commonly this approach involves immunoprecipitation of
the epitope-tagged form of the target protein. The use of denaturing lysis and
affinity purification conditions helps to ensure that they type of interaction between
the target protein and Smt3p is covalent in nature. This also helps in removal of
non-covalently bound proteins as well as in the inhibition of SUMO proteases.
Presence of a band in the immunoblot (probed with antibodies against the epitope
tag) will confirm that the protein target is indeed a substrate of Smt3p. If antibodies
for the protein substrates are available, then we can expect two bands in the
immunoblots – one corresponding to the unmodified form of the protein substrate
and another slower migrating band that will correspond to the SUMO-modified
form.

Non-ligatable Smt3p mutants serve as a good control for substrate validation
The inactivated forms of UBLs require maturation before participation in the
conjugation reaction. UBL proteases cleave the terminal residues of UBLs to reveal a
diglycine (GG) motif that is necessary for isopeptide bond formation with the

99

acceptor Lys residue on target proteins. The evolutionary conservation of the GG
motif across UBLs would suggest an absolute requirement for the GG motif in
attachment to protein substrates. We have generated a series of C-terminal mutants
of Smt3p all expressing the same His6-3FLAG double epitope tag described in
Chapter 3. Immunoblotting analyses have shown that the deletions of any or all of
the GG motif (GΔG and ΔGG) prevents formation of Smt3p adducts. These mutant
strains where Smt3p cannot be conjugated to target proteins are useful in the
affinity purification procedures used for the proteomics studies as proteins that are
carried through the two purifications are highly abundant proteins and can be safely
removed from the tagged Smt3p dataset.

Undoubtedly more work will have to be undertaken to completely elucidate
the protein substrates of Smt3p as well as the mechanisms by which Smt3p
modification of these proteins regulates critical cellular pathways. For these
purposes, Tetrahymena is a very useful model system as it exhibits nuclear
dimorphism and allows for powerful forward and reverse genetics which will
certainly provide insights into the essential nature of Smt3p. Studies such as ours
are the first step in this approach and yield useful catalogue of proteins that are
Smt3p substrates.
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Figure 15. SMT3 KO heterokaryons undergo normal DNA elimination events during
conjugation. Wild type (wt) and SMT3 KO heterokaryons (SMT3het) were mixed in
three matings: wt × wt, wt × SMT3het, SMT3het × SMT3het. Cell lysates for PCR were
prepared at mixing (t0). At 2 hours, >500 mated pairs were hand isolated into drops
for each mating. After 24 hours (t24) when conjugation was complete the progeny
were lysed and used as template in PCR reactions. The assay utilizes oligonucleotide
primers that are able to amplify the unrearranged and rearranged forms of two IES
elements (M and R). Comparison of PCR-amplified products on ethidium-bromide
stained agarose gels, allowed visualization of the IES excision products. Only the
longer 593 bp unrearranged form of the M element was found in the cells at t0, but
the shorter 279 bp rearranged M element was the major product from progeny cells
at t24 hours. This confirms that normal M element rearrangement occurred in
progeny of SMT3 KO heterokaryons. There is only one R element product in the
MAC but the amplified products are the same at t0 and t24 as expected in for normal
excision. Schematic of IES products following arrangement are shown below.
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Figure 16. Induction of the MTT1 promoter with cadmium allows SMT3 and UBA2
conditional mutants to conjugate normally. SMT3 and UBA2 conditional strains
grown and starved in the absence of cadmium are unable to form pairs when mixed
together to induce conjugation. When CdCl2 (0.1 μg/mL) is added to these cells prior
to mixing, these cells are able to form pairs and undergo normal conjugation. These
mated cells were fixed and then stained with DAPI (to stain for nuclei). The timepoints shown here are at 2-2.5 hours (crescent micronuclei), 6 hours (pronuclei
formation) and 8 hours (MAC Development). Wild-type cells induced with the same
amount of cadmium were used as control here.

Table 6. List of oligos used in this study.
Purpose
GFP constructs

Name
bzSUMO+1F
bzSUMO+930R
bzUBA2+1F
bzUBA2+2262R

Sequence (5’>3’)
CACCAATAAAATGACTGATTAAAACGCTAACGCT
GATATCGAAAGAGCCACCAACTTGTTC
CACCAAGGATATGAGTTTAGGAAGAATAAATC
GATATCCACTTTTAACTTTTTGTTGTCT

Knockout cassette

SMT3 5’flank F
SMT3 5’flank R
SMT3 3’flank F
SMT3 3’flank R
UBA2 5’flank F
UBA2 5’flank R
UBA2 3’flank F
UBA2 3’flank R

GTCACTCGAGGCAGTTTGTCTTTTATCCATTT
GCCGAGATCTCTTCAAATATTTATTGTTCGAC
ATCGGGATCCCTTCAAAATTTAGTTGATTGTGATAACA
ATTAGCGGCCGCATCTCAAATAAGTCTAAAT
ATCGCTCGAGAGTACTCGACGGATCTCATAAA
CGGCGGATCCACTCATATCCTTATCAATTAAA
ACGTGGATCCAAAGCTGTAGATTTTAGTTAAA
AACAGCGGCCGCTAGCTTATTAATTCTTCTA

PCR to confirm knockout lines

SMT3WT upstream F
SMT3WT upstream R
UBA2WT upstream F
UBA2WT upstream R
MTTp 1940R

GATTGTTTGATGCTACATTCCTTC
TGCTAAAGACGGTTGGCTCT
TTTGCTTGTTGTTTGGTTTGTTT
CCAATGCCTCCTACACCAAT
TTTGCTAACCATAGCCAAAAT

RT-PCR assay of conditional
line

SMT3WT 3’UTR F

ACTGATTAAAACGCTAACGCT

SMT3WT 3’UTR R

ATTAGTTTATAAGCAAGCACATAC
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BTU1 3’UTR R
NEO3 3’ UTR F
NEO3 3’ UTR R

GTTGGTTTAGCTGACCGATTC
ACCGCTATCAGGACATA
GCAGACAAATTTTTAAGAGC
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Table 7. List of identified Smt3p protein substrates from vegetative Tetrahymena.
TGD ID
TTHERM_00410130
TTHERM_00641240
TTHERM_00585260
TTHERM_00339620
TTHERM_00346510
TTHERM_00346560
TTHERM_00085200
TTHERM_01014750
TTHERM_00245410

TTHERM_00529790
TTHERM_00196370
TTHERM_00399360
TTHERM_00140850
TTHERM_00185230
TTHERM_00028780
TTHERM_00046480

Gene
Name

Description

Small ubiquitin-related modifier (SUMO), conjugated to lysine residues
on target proteins, post-translational modification.
GPM1 Phosphoglycerate mutase.
ATP2 ATP synthase beta chain, mitochondrial precursor, putative.
RPL40 Ubiquitin-60S ribosomal protein L40.
Ubiquitin family protein.
Ubiquitin family protein.
Ubiquitin family protein.
dnaK protein belongs to the heat shock protein 70 family.
Heterochromatin protein 1, putative, Chromo (CHRromatin Organisation
MOdifier) domain.
Citrate synthase; bifunctional 14-nm filament-forming protein; structural
protein involved in oral morphogenesis and pronuclear behavior during
CIT1
conjugation; citrate synthase activity decreased by polymerization and
dephosphorylation.
HSP60 HSP60; TCP-1/cpn60 chaperonin family protein.
Hypothetical protein.
SMT3

ENO2

Hypothetical protein.
Triosephosphate isomerase.
Hypothetical protein.
ENOlase; enolase family protein.

IIndependent
Identified
5
4
2
5
3
2
5

2

3
5
2
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TTHERM_00105110
TTHERM_00125640
TTHERM_00558440
TTHERM_00143660

TTHERM_00476670
TTHERM_01528510
TTHERM_00487110
TTHERM_00375130
TTHERM_00895810
TTHERM_01029940
TTHERM_00075670
TTHERM_01014740
TTHERM_01113100

TTHERM_00068170
TTHERM_00445980

Putative 70-kDa heat-shock protein (hsp70); two forms of hsp70
associate with tubulin, mitochondrial hsp70 associates with 14-nm
HSP70
filament protein (14FP), hsp70 proteins have evolutionarily conserved
roles in folding nascent polypeptides.
SSA3 HSP70a paralog; dnaK protein.
SSA5

HSP70a paralog; dnaK protein.
Histone H2A (variant H2A.Z); essential protein; regulated by acetylation,
which modulates charge patch on its N-terminal tail; comprises about
HTA3
20% of total H2A protein in Tetrahymena; found only in transcriptionally
active nuclei.
Ribosomal Protein of the Large subunit #20; Homolog of Yeast RPL20,
RPL20
Human RPL18A; Ribosomal L18ae protein family protein.
Hypothetical protein.
PRE10 20S proteasome core alpha subunit 7.
Carboxyvinyl-carboxyphosphonate phosphorylmutase-related.
Hypothetical protein.
Hypothetical protein.
Ribosomal Protein of the Large subunit #43; Homolog of Yeast RPL43,
RPL43
Human RPL37A.
Hypothetical protein.
40S ribosomal protein RACK1 (Receptor for Activated C Kinase 1);
homolog of yeast ASC1.
Tetrahymena Calcium-Binding protein; 25 kD Ca(2+)-binding protein
containing four EF-hand loops; localized to cell cortex except in and
TCB2
around basal bodies, and around both the migratory and the stationary
gametic pronuclei during pronuclear exchange.
Metallopeptidase family M24 containing protein.

2
2

3
4

2

3
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TTHERM_00926980
TTHERM_00068120
TTHERM_00028740
TTHERM_00467660
TTHERM_01100380

Acetyl-CoA acyltransferases family protein.
Hypothetical protein, acyltransferase domain.
Ribosomal Protein of the Large subunit #12; Homolog of Yeast RPL12,
RPL12 Human RPL12, Bacterial RPL11; Ribosomal protein L11; RNA binding
domain containing protein.
Ribosomal Protein of the Small subunit 24; Homolog of yeast RPS24,
RPS24
human RPS24.
Hypothetical protein.

TTHERM_00068140
TTHERM_00522720

Succinyl-CoA synthetase, alpha subunit family protein.
UBC9

TTHERM_00420030
TTHERM_00216150
TTHERM_00333210

RPL4

TTHERM_01108700

PGI1

TTHERM_00571860
TTHERM_00535530
TTHERM_00522810

ATP1

TTHERM_00047080
TTHERM_00250870
TTHERM_00011390
TTHERM_00294870

SUMO-conjugating enzyme involved in the Smt3p conjugation pathway; a
member of the ubiquitin-conjugating enzyme E2 family.
Phosphoenolpyruvate carboxykinase.
Hypothetical protein, Telomere stability and silencing; telomere stability
C-terminal domain; Sde2 domain.
Ribosomal Protein of the large subunit; ribosomal protein L4/L1 family
protein
Glycolytic enzyme phosphoglucose isomerase, catalyzes the
interconversion of glucose-6-phosphate and fructose-6-phosphate.
ATP synthase F1; alpha subunit family protein.
Hypothetical protein.
Hypothetical protein.
Succinate dehydrogenase; flavoprotein subunit containing protein.
Dual specificity phosphatase; catalytic domain containing protein.
Hypothetical protein.
Hypothetical protein.

2

3

2
2
2
4
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TTHERM_01289110
TTHERM_00053800
TTHERM_00128280
TTHERM_00225860
TTHERM_01109770
TTHERM_00152140
TTHERM_00780640
TTHERM_00667010
TTHERM_01146030
TTHERM_00047230
TTHERM_00047580
TTHERM_00393040
TTHERM_00859260

TTHERM_00938820

Ribosomal protein of the large subunit; Homolog of yeast RPL15
(/RPL15e).
FAD binding domain containing protein.
Deep fiber bundle protein 1; localizes to the deep fiber bundle of the oral
DFB1 apparatus, forms filamentous structures, associates with basal bodies
and longitudinal microtubules.
C2 domain. This repeat is found in a wide variety of proteins and
generally consists of the motif XYPPX where X can be any amino acid.
Ribosomal Protein of the Small subunit 11; Homolog of yeast RPS11,
RPS11
human RPS, bacterial RPS17.
Brix domain containing protein. Proteins from the Imp4/Brix
superfamily appear to be involved in ribosomal RNA processing, which
essential for the functioning of all cells.
Hypothetical protein.
HSA domain (domain is predicted to bind DNA and is often found
associated with helicases).
Catalase; peroxisomal enzyme involved in the metabolism of hydrogen
CAT1
peroxide; enzyme activity induced by linolenic acid.
Myb/SANT-like DNA-binding domain.
Uroporphyrinogen decarboxylase family protein.
Hypothetical protein.
EF-1 guanine nucleotide exchange domain containing protein. Eukaryotic
elongation factor 1 beta central acidic region; EF-1 guanine nucleotide
exchange domain.
Eukaryotic translation Elongation Factor; catalyzes ribosomal
translocation during protein synthesis; mRNA is expressed during
EEF2
vegetative growth; high amino acid identity with EF-2 in other
eukaryotes

RPL15

2

2
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TTHERM_00736480
TTHERM_00499390
TTHERM_01094890
TTHERM_00245120
TTHERM_00852720
TTHERM_01043090

TTHERM_00691610

TTHERM_01299660
TTHERM_00971960
TTHERM_00044990

RPL5

Ribosomal L18p/L5e family protein
Glycine cleavage system T protein. Sequence similarity to the HisK
protein kinase family. The system is a series of enzymes that are
triggered in response to high concentrations of the amino acid glycine.
Hypothetical protein.

Hypothetical protein.
Zinc finger, C2H2 type.
Ribosomal Protein of the Small subunit 27; Homolog of yeast RPS27,
RPS27
human RPS27
CAP-Gly domain containing protein. CAP domain containing proteins are
involved in organizing microtubules. The CAP-Gly domain is a conserved
glycine-rich variant of the CAP domain. CAP-Gly domain bind to Cterminal sequence motifs present in α-tubulin and in other microtubuleassociated proteins.
SCP-2 sterol transfer family protein. Sterol carrier proteins (also known
as nonspecific lipid transfer proteins) is a family of proteins that transfer
steroids and probably also phospholipids and gangliosides between
cellular membranes.
Hypothetical protein.
Fumarylacetoacetase family protein; FAA_hydrolase domain.

TTHERM_00486310

Hypothetical protein.

TTHERM_00066950

Pyridine nucleotide-disulphide oxidoreductase family protein.

TTHERM_01097920

Hypothetical protein.

TTHERM_01001220
TTHERM_01129660

2
2

2

2

2

Hypothetical protein.
Ribosomal Protein of the Large subunit 36; Homolog of Yeast RPL36,
RPL36
Human RPL36; Ribosomal protein L36e containing protein.
124

TTHERM_00487090
TTHERM_00522370
TTHERM_00149300
TTHERM_00773350
TTHERM_00762890
TTHERM_00006320
TTHERM_01020870

Fructose-bisphosphate aldolase class-I family protein.
Cation channel family protein; ion transport protein.
Ribosomal Protein of the Small subunit 4; Homolog of yeast RPS4, human
RPS4
RPS4.
Hypothetical protein.
Ribosomal Protein of the Small subunit 17; Homolog of yeast RPS17,
RPS17
human RPS17.
Tetrin A; novel, insoluble cytoskeletal protein with molecular mass of
TTNA
around 85 kD; unique to cilia.
Zinc finger, C2H2 type family protein.

TTHERM_00157949
SOD1

TTHERM_00011400

Myb-like DNA-binding domain containing protein.
Ribosomal Protein of the Large subunit #22; Homolog of Yeast RPL22,
RPL22
Human RPL22.
CCT motif family protein.

TTHERM_01053030

Superoxide dismutase.

TTHERM_00402120

Glutathione S-transferase, N-terminal domain containing protein.

TTHERM_00415630

Hypothetical protein.

TTHERM_00299840
TTHERM_00151850
TTHERM_00444800
TTHERM_00134940
TTHERM_00379050

2

Hypothetical protein.

TTHERM_00357080
TTHERM_00227270

2

2

Methylmalonate-semialdehyde dehydrogenase family protein.
Ser/Thr protein phosphatase family protein, Calcineurin-like
phosphoesterase superfamily domain.
Hypothetical protein.
Ribosomal Protein of the Large subunit #25; Homolog of Yeast RPL25,
RPL25 Human RPL23A, Bacteria RPL23; Ribosomal protein L23 containing
protein.
PRE2 20S proteasome core beta subunit 5.
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TTHERM_00499420
TTHERM_00568050
TTHERM_00361490
TTHERM_00145440
TTHERM_01026240
TTHERM_00518610
TTHERM_00535700
TTHERM_00824010

TGP1

DIM1

TTHERM_00046870
TTHERM_01035740
TTHERM_00400750
TTHERM_00678260
TTHERM_00429890
TTHERM_00565590

MYO2

G-quartet DNA-binding protein TGP1.
HMG (high mobility group) box family protein.
Hypothetical protein.
Alpha/beta hydrolase family protein.
Phytanoyl-CoA dioxygenase (PhyH).
Mitosis protein DIM1.
RING-variant domain, FHA domain protein, putative.
Ubiquitin-conjugating enzyme, putative.
Phosphoglucomutase/phosphomannomutase, C-terminal domain
containing protein.
Myosin heavy chain; member of proposed myosin Class XX, distinct from
previously defined myosin classes; contains predicted coiled-coil, myosin
tail homology (MyTH4), and FERM domains.
D-hydantoinase family protein; Amidohydrolase family; Carbon-nitrogen
hydrolase.
Tetrahymena homolog of the liver F-Antigen; Homolog of vertebrate liver
F-antigen; constituent of the intracellular membrane network; associated
with membranes of the Golgi apparatus and transport vesicles.
Nucleoplasmin protein.
Hypothetical protein.

2
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Table 8. Smt3p substrates identified from both native and denaturing conditions of lysis.
TGD ID
TTHERM_00339620

Gene
Name
RPL40

TTHERM_00346560
TTHERM_00105110

HSP70

TTHERM_01014750
TTHERM_00216150
TTHERM_00196370

HSP60

TTHERM_00852720
TTHERM_01014740
TTHERM_00499420

TGP1

TTHERM_00859260
TTHERM_00140850
TTHERM_01146030

CAT1

TTHERM_01029940
TTHERM_00068140
TTHERM_00415630
TTHERM_00558440

SSA5

TTHERM_00429890
TTHERM_00938820

EEF2

TTHERM_00245410
TTHERM_00499390
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